{"gene":"USP16","run_date":"2026-04-28T21:43:01","timeline":{"discoveries":[{"year":1999,"finding":"USP16 (Ubp-M) is phosphorylated at the onset of mitosis and dephosphorylated during the metaphase/anaphase transition; purified recombinant Ubp-M deubiquitinates histone H2A in vitro; the wild-type protein localizes to the cytoplasm, while catalytically inactive mutants (lacking the active-site cysteine) associate with mitotic chromosomes and cause cell cycle arrest and apoptosis upon transfection.","method":"In vitro deubiquitination assay with recombinant protein; in vitro phosphorylation with mitotic extracts and purified cdc2/cyclin B; GFP-fusion live-cell imaging; transfection of mutant constructs with viability readout","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro enzymatic assay, mutagenesis, direct localization imaging, and functional cell-cycle phenotype in a single foundational study","pmids":["10077596"],"is_preprint":false},{"year":2007,"finding":"The BUZ domain of Ubp-M (USP16) adopts a structure with three zinc-binding sites forming a pair of cross-braced ring fingers within a third zinc finger; this domain specifically recognizes the free C-terminal tail of ubiquitin (GlyGly-COOH), and any modification of the G76 carboxylate abolishes binding, defining a 'free ubiquitin sensor' function.","method":"NMR solution structure determination; ubiquitin-binding mapping by NMR; fluorescence polarization binding assays with C-terminal ubiquitin peptides","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with functional binding validation by multiple assays","pmids":["17512543"],"is_preprint":false},{"year":2010,"finding":"The BUZ domain of Ubp-M (USP16) exhibits sequence-specific recognition of C-terminal GlyGly-containing peptides; it binds the histone H3–H4 tetramer complex in vitro pull-down, and its sequence specificity differs from that of the HDAC6 BUZ domain.","method":"One-bead-one-compound peptide library screening; alanine scanning; fluorescence polarization binding assays; in vitro pull-down with histone complexes","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted binding with multiple orthogonal methods and mutagenesis","pmids":["21090589"],"is_preprint":false},{"year":2013,"finding":"Triplication of Usp16 in Ts65Dn (Down syndrome model) mice reduces self-renewal of hematopoietic stem cells, mammary epithelial cells, neural progenitors, and fibroblasts; Usp16 removes ubiquitin from histone H2A lysine 119 (H2AK119); elevated Usp16 is associated with decreased ubiquitination of Cdkn2a and accelerated senescence; reduction of Usp16 by one allele or siRNA rescues these defects.","method":"Mouse genetic model (Ts65Dn trisomic); siRNA knockdown; colony and self-renewal assays; histone H2A deubiquitination assays; senescence assays; human tissue overexpression/knockdown experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal genetic and biochemical methods, replicated in mouse and human systems, highly cited foundational study","pmids":["24025767"],"is_preprint":false},{"year":2013,"finding":"CDK1 (cyclin-dependent kinase 1)/cyclin B phosphorylates USP16 (Ubp-M) at serine 552; this phosphorylation is required for G2/M cell cycle progression and reduces interaction with the nuclear export protein CRM1, thereby facilitating USP16 nuclear localization during mitosis; S552 phosphorylation does not affect deubiquitination activity or substrate specificity.","method":"Mass spectrometry identification of phosphorylation site; in vitro kinase assay with purified CDK1/cyclin B; in vivo phosphorylation assays; co-immunoprecipitation with CRM1; cell cycle analysis by flow cytometry","journal":"Cell cycle","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro kinase assay plus in vivo validation, MS identification, functional cell cycle phenotype","pmids":["24013421"],"is_preprint":false},{"year":2014,"finding":"USP16 interacts with HERC2 through its coiled-coil domain (HERC2 binds via its C-terminal HECT domain); HERC2 knockdown affects ubiquitinated H2A levels through USP16; USP16 levels increase in response to DNA damage in a HERC2-dependent manner; increased USP16 negatively regulates DNA damage-induced ubiquitin foci formation and downstream factor recruitment; USP16 deubiquitinates both H2AK119 and H2AK15 ubiquitination in vitro.","method":"Co-immunoprecipitation; domain-mapping experiments; in vitro deubiquitination assay; siRNA knockdown; immunofluorescence for ubiquitin foci; DNA damage response assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro enzymatic assay, reciprocal co-IP domain mapping, and multiple functional readouts","pmids":["25305019"],"is_preprint":false},{"year":2015,"finding":"Conditional deletion of Usp16 in mouse bone marrow increases global H2AK119 ubiquitination and causes lethality with dramatic reduction of mature hematopoietic and progenitor cells; ChIP-seq showed Usp16 bound hematopoietic regulator genes; Usp16 and PRC1 counterbalance each other for H2A ubiquitination; Usp16 deletion alters cell cycle via upregulation of Cdkn1a (p21), and Cdkn1a knockdown rescues the differentiation defect.","method":"Conditional knockout mouse; ChIP-seq; RNA-seq; flow cytometry; PRC1 subunit knockdown rescue experiment; cell cycle analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with multiple orthogonal genomic and functional assays, genetic epistasis with PRC1 and Cdkn1a","pmids":["26699484"],"is_preprint":false},{"year":2015,"finding":"USP16 deubiquitinates Plk1 (Polo-like kinase 1), enhancing its interaction with kinetochore protein BubR1 and retaining Plk1 at kinetochores during early mitosis; USP16 knockdown increases Plk1 ubiquitination and decreases kinetochore-localized Plk1, causing chromosome misalignment.","method":"Co-immunoprecipitation; ubiquitination assays; siRNA knockdown; immunofluorescence for kinetochore localization; chromosome alignment assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, ubiquitination assay, direct localization imaging with functional chromosome alignment readout","pmids":["26323689"],"is_preprint":false},{"year":2018,"finding":"Usp16 modulates the Wnt signaling pathway in mammary epithelia, fibroblasts and MEFs; reduced Usp16 increases tissue responsiveness to Wnt (upregulation of Axin2), expands the basal mammary compartment, and increases regeneration; this regulation is mediated at least partly through Cdkn2a activation and affects Rspo-mediated phosphorylation of LRP6; in Down syndrome model (Ts65Dn), extra Usp16 copy dampens Wnt activation, and genetic Wnt upregulation rescues proliferation defects.","method":"Mouse genetic models (Usp16 reduction, Ts65Dn); mammary epithelial regeneration assays; Wnt target gene expression; LRP6 phosphorylation western blot; in vitro and in vivo epithelial repopulation assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple genetic models and functional assays but pathway placement is indirect (LRP6 phosphorylation) without full reconstitution","pmids":["30504774"],"is_preprint":false},{"year":2019,"finding":"Calcineurin A (CNA) is constitutively ubiquitinated on K327 with K29-linked polyubiquitin chains, impairing NFAT recruitment; USP16 removes this ubiquitin in response to intracellular calcium stimulation, enabling NFAT-targeted gene transcription; USP16 deficiency prevents calcium-triggered CNA deubiquitination, causing defective T cell maintenance and proliferation; T cell-specific USP16 knockout mice show reduced autoimmune encephalitis and IBD severity.","method":"Co-immunoprecipitation; ubiquitination assays identifying K327 site and K29 linkage; T cell-specific knockout mice; NFAT transcription reporter assays; in vivo disease models (EAE, IBD)","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — site-specific ubiquitination mapping, conditional KO with multiple in vivo disease readouts, mechanistic link to NFAT signaling","pmids":["31135381"],"is_preprint":false},{"year":2020,"finding":"USP16 is predominantly cytoplasmic during all interphase cell cycle phases due to a nuclear export signal (NES) that drives CRM1-dependent export; a non-canonical nuclear localization signal (NLS) has minimal role in nuclear entry; USP16 is only transiently retained in the nucleus after mitosis; forced nuclear localization of USP16 abolishes DNA double-strand break (DSB) repair, indicating that cytoplasmic exclusion protects nuclear DSB repair from unrestrained USP16 DUB activity.","method":"Fluorescence live-cell imaging; NES/NLS mutant analysis; leptomycin B treatment (CRM1 inhibition); DNA damage assays with enforced nuclear USP16; cell fractionation","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiments with mutational dissection, functional consequence for DSB repair established","pmids":["32005696"],"is_preprint":false},{"year":2020,"finding":"USP16 is a component of late cytoplasmic pre-40S ribosomal subunits; it deubiquitinates an internal lysine of ribosomal protein RPS27a/eS31; USP16 deletion causes defects in final 18S rRNA processing and retarded recycling of late-acting ribosome biogenesis factors, revealing a role in the ultimate step of 40S subunit maturation; RPS27a ubiquitination depends on active translation.","method":"Mass spectrometry of pre-ribosomal complexes trapped on RIOK1; USP16 deletion; northern blot for rRNA processing; factor recycling assays; ubiquitination analysis of RPS27a","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — MS identification in native complex, genetic deletion with specific rRNA processing phenotype, and biochemical substrate mapping","pmids":["32129764"],"is_preprint":false},{"year":2021,"finding":"USP16 deubiquitinates and stabilizes c-Myc protein; USP16 interacts with c-Myc by co-immunoprecipitation and co-localization; USP16 depletion suppresses proliferation of castration-resistant prostate cancer cells in vitro and in vivo; c-Myc overexpression rescues USP16 depletion phenotype.","method":"Co-immunoprecipitation; ubiquitination assays; shRNA knockdown; xenograft mouse model; c-Myc rescue experiment","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2–3 — co-IP and ubiquitination assay with in vivo rescue, but in vitro deubiquitination reconstitution not described","pmids":["33546726"],"is_preprint":false},{"year":2021,"finding":"USP16 deubiquitinates IKKβ on K238, and this deubiquitination selectively promotes IKKβ-mediated phosphorylation of p105 (NF-κB1) without directly affecting p65 or IκBα phosphorylation; myeloid-conditional USP16 knockout mice exhibit reduced IBD severity.","method":"Mass spectrometry identification of IKKβ ubiquitination site; co-immunoprecipitation; ubiquitination assays; myeloid-specific conditional KO mouse; IBD disease model; substrate-specific phosphorylation analysis","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 — MS site identification, mechanistic substrate specificity demonstrated, conditional KO in vivo validation","pmids":["33523871"],"is_preprint":false},{"year":2021,"finding":"USP16 interacts with and deubiquitinates JAK1, thereby promoting JAK1 signaling and lung tumor growth in K-RAS-driven tumorigenesis; Usp16 deletion in mice significantly attenuates K-rasG12D-induced lung tumorigenesis; USP16 upregulation upon RAS activation also prevents ROS-induced p38 activation.","method":"Co-immunoprecipitation; ubiquitination assays; Usp16 conditional KO in K-rasG12D mouse lung tumor model; ROS and p38 signaling analysis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 — co-IP and ubiquitination assay with in vivo genetic model, but in vitro JAK1 deubiquitination reconstitution not shown","pmids":["34294846"],"is_preprint":false},{"year":2022,"finding":"USP16 is the major deubiquitinase for H2AK119ub1 in mouse oocytes; conditional knockout of Usp16 in oocytes does not impair survival, growth, or meiotic maturation, but causes defects in zygotic genome activation and developmental competence after fertilization, associated with high levels of maternal H2AK119ub on zygotic genomes; ChIP-seq revealed H2AK119ub1 is enriched at TSSs of maternal genes in fully grown oocytes and declines during meiotic resumption in a USP16-dependent manner.","method":"Oocyte-specific conditional knockout; ChIP-seq for H2AK119ub1 genome-wide; embryo development assays; immunofluorescence","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with genome-wide ChIP-seq and specific developmental phenotype","pmids":["35640597"],"is_preprint":false},{"year":2022,"finding":"Reduction of USP16 in a mouse Alzheimer's disease model prevents neural precursor cell (NPC) self-renewal defects, cognitive deficits, and astrogliosis in vivo; this operates through decreased Cdkn2a expression and mitigation of aberrant BMP signaling pathway activation, identifying BMP pathway regulation as a novel USP16 function.","method":"Mouse AD model; genetic reduction of USP16; NPC self-renewal assays; in vivo cognitive testing; astrogliosis quantification; gene expression analysis for Cdkn2a and BMP pathway","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic model with cognitive and cellular phenotypes, but BMP mechanistic link relies on expression analysis rather than direct biochemical demonstration","pmids":["35311644"],"is_preprint":false},{"year":2023,"finding":"USP16 interacts with and deubiquitinates KEAP1; FGF18 treatment reduces USP16 levels, leading to increased KEAP1 ubiquitination and Nrf2 activation; Nrf2 directly binds the USP16 promoter forming a negative feedback loop; this USP16/KEAP1/Nrf2 axis mediates FGF18 protection against hepatic ischemia-reperfusion injury.","method":"Co-immunoprecipitation; ubiquitination assays; ChIP for Nrf2 binding to USP16 promoter; USP16 knockdown/overexpression; hepatic IRI mouse model; HSC-specific FGF18 deletion","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, ubiquitination assay, ChIP, and in vivo genetic models establishing the pathway","pmids":["37777507"],"is_preprint":false},{"year":2023,"finding":"USP16 is an ISG15 cross-reactive protease identified by ISG15 activity-based profiling; recombinant USP16 cleaves pro-ISG15 and ISG15 isopeptide-linked model substrates in vitro, and deISGylates substrates from cell lysates; USP16 depletion increases interferon-induced ISGylation; USP16-dependent ISG15 substrates include metabolic enzymes (malate dehydrogenase, SOD1, fructose-bisphosphate aldolase A, glutamic-oxaloacetic transaminase 1).","method":"ISG15 activity-based profiling; in vitro cleavage assays with recombinant USP16 and ISG15 substrates; USP16 depletion with ISGylation analysis; interactome profiling of ISG15 substrates","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic reconstitution with activity-based profiling and substrate identification","pmids":["38055744"],"is_preprint":false},{"year":2023,"finding":"USP16 has dual ubiquitin/Fubi cleavage activity; chemoproteomics using a chemical tool kit identified USP16 alongside USP36 as Fubi proteases; USP16 plays a synergistic role in Fubi-S30 maturation, which is required for translationally competent ribosomes.","method":"Chemoproteomics with Fubi activity-based probes; in vitro Fubi cleavage assays; Fubi C-terminal hydrolase measurements; functional maturation assays","journal":"Nature chemical biology","confidence":"High","confidence_rationale":"Tier 1 — chemoproteomics discovery plus in vitro enzymatic reconstitution","pmids":["37443395"],"is_preprint":false},{"year":2023,"finding":"USP16 deubiquitinates and stabilizes Drp1 through direct interaction; USP16 is upregulated in MSU-stimulated macrophages and promotes gouty arthritis via Drp1-dependent mitochondrial fission and NF-κB/NLRP3 inflammasome activation.","method":"Co-immunoprecipitation; GST pull-down; ubiquitination assays; transmission electron microscopy of mitochondria; NLRP3 inflammasome activation assays; gouty arthritis mouse model","journal":"Arthritis research & therapy","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct interaction by co-IP and GST pulldown with ubiquitination assays, but reconstituted deubiquitination of Drp1 not explicitly shown","pmids":["37488647"],"is_preprint":false},{"year":2024,"finding":"Cryo-EM structure of USP16 bound to H2AK119Ub nucleosome reveals a mode of H2AK119Ub deubiquitination fundamentally distinct from that of PR-DUB: USP16 recognizes the nucleosome independently of the H2A-H2B acidic patch, and shows conformational heterogeneity in the ubiquitin motif and H2A C-terminal tail.","method":"Cryo-EM structure determination of USP16-H2AK119Ub nucleosome complex","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure with functional mechanistic insight and comparison to PR-DUB mechanism","pmids":["38918638"],"is_preprint":false},{"year":2024,"finding":"USP16 is O-GlcNAcylated on Thr203 and Ser214; mutation of Thr203 (adjacent to catalytic Cys204) reduces deubiquitination activity toward H2AK119ub in vitro and in cells, while Ser214 mutation has the opposite effect; O-GlcNAcylation antagonizes CDK1-mediated S552 phosphorylation and promotes USP16 nuclear export; O-GlcNAcylation is required for deubiquitination of Plk1 and subsequent proper chromosome segregation and cytokinesis.","method":"Site-specific O-GlcNAc mutant analysis; in vitro H2A deubiquitination assays; phosphorylation-specific antibody; nuclear export assays; Plk1 ubiquitination assays; chromosome segregation and cytokinesis imaging","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro enzymatic assay with site-specific mutagenesis, multiple substrates tested, and functional cell division phenotype","pmids":["38462164"],"is_preprint":false},{"year":2025,"finding":"PRC1 and USP16 are both localized in mitochondria (in addition to the nucleus); mitochondria-specific depletion of PRC1 subunit RING2 alters ubiquitination of mitochondrial proteins including H2Aub; disruption of PRC1 causes alterations in mitochondrial proteome, mitochondrial integrity, and impaired respiratory function.","method":"Immunofluorescence; proximity ligation assays; cell fractionation; biochemical analyses of isolated/affinity-purified mitochondria; auxin-inducible mitochondria-specific RING2 depletion; proteomics; mitochondrial respiration assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — multiple localization methods plus functional mitochondrial phenotype, but USP16's specific mitochondrial enzymatic activity not fully reconstituted","pmids":["41086206"],"is_preprint":false},{"year":2025,"finding":"USP16 S-nitrosylation at C731 by iNOS impairs its deubiquitinase activity toward KDM1A; during coronary microembolization, reduced USP16 activity leads to K355 ubiquitination and degradation of KDM1A, which normally removes H3K9me1/2 from GCLM and GLS promoters to maintain glutathione homeostasis.","method":"Site-specific S-nitrosylation identification; ubiquitination assays for KDM1A K355; ChIP for KDM1A at GCLM/GLS promoters; USP16 knockdown/overexpression; CME mouse model","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2–3 — site-specific PTM identified with functional downstream pathway, but direct in vitro reconstitution of SNO-USP16 effect on KDM1A deubiquitination not fully shown","pmids":["41339351"],"is_preprint":false},{"year":2025,"finding":"The ZnF-UBP domain of USP16 can bind ubiquitin substrates but also serves as a crucial regulator of enzyme kinetics by relieving product inhibition: after Ub cleavage, slow release of Ub from the catalytic domain causes product inhibition, which the ZnF-UBP domain overcomes in cis by capturing the released ubiquitin product; supplying the ZnF-UBP domain in trans activates USP16 and other USP enzymes.","method":"In vitro kinetic analysis of USP16 and ZnF-UBP domain mutants; trans-activation experiments with isolated ZnF-UBP domain; comparison across 8 of 14 ZnF-UBP-containing USPs","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinetic reconstitution with domain mutants, mechanistic enzyme kinetics demonstrating product inhibition relief","pmids":["bio_10.1101_2025.09.28.679104"],"is_preprint":true},{"year":2026,"finding":"USP16 deubiquitinates and stabilizes NLRP3 in keratinocytes by removing K48-linked ubiquitination, thereby enhancing inflammasome activity; keratinocyte-specific USP16 knockdown ameliorates psoriatic phenotypes including epidermal hyperplasia; NLRP3 activator or overexpression counteracts the therapeutic effects of USP16 reduction.","method":"Co-immunoprecipitation; ubiquitination assays; RNA-seq; keratinocyte-specific knockdown; psoriasis mouse model; rescue experiments with NLRP3 activator","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2–3 — co-IP and ubiquitination assay with in vivo rescue, specific K48 ubiquitination site identified","pmids":["41591834"],"is_preprint":false},{"year":2026,"finding":"USP16 deubiquitinates and stabilizes E2F1 through direct interaction; stabilized E2F1 transcriptionally activates Notch1; this USP16/E2F1/Notch1 axis drives M2 macrophage polarization in colorectal cancer.","method":"Co-immunoprecipitation; ubiquitination assays; E2F1 and Notch1 rescue/knockdown experiments; macrophage polarization assays; conditioned medium tumor proliferation/invasion assays","journal":"Cytotechnology","confidence":"Medium","confidence_rationale":"Tier 2–3 — co-IP and ubiquitination with functional rescue, but in vitro E2F1 deubiquitination reconstitution not described","pmids":["41873345"],"is_preprint":false},{"year":2026,"finding":"LPS-induced RUNX2 transcriptionally activates USP16 expression; USP16 then deubiquitinates mitoferrin-2 (MFRN2) at K97, removing K27-linked ubiquitin chains and stabilizing MFRN2, which leads to mitochondrial iron dyshomeostasis and epithelial ferroptosis in sepsis-induced acute lung injury.","method":"ChIP for RUNX2 binding to USP16 promoter; ubiquitination assays for MFRN2 K97; USP16 overexpression/knockdown; ferroptosis assays; ALI mouse model","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2–3 — ChIP, site-specific ubiquitination mapping, and in vivo model, but direct in vitro reconstitution of USP16 deubiquitinating MFRN2 not fully demonstrated","pmids":["41894390"],"is_preprint":false},{"year":2020,"finding":"USP16 deubiquitinates and stabilizes LDL receptor (LDLR), preventing ubiquitylation-dependent LDLR degradation and thereby promoting LDL uptake.","method":"Co-immunoprecipitation; ubiquitination assays; LDL uptake assays; USP16 overexpression/knockdown","journal":"International heart journal","confidence":"Low","confidence_rationale":"Tier 3 — co-IP and ubiquitination assay without in vitro reconstitution, single study","pmids":["32999190"],"is_preprint":false},{"year":2022,"finding":"MNX1-AS1 lncRNA recruits USP16 to suppress IGF2BP3 degradation (deubiquitination), stabilizing IGF2BP3 and sustaining Hippo pathway inactivation in gallbladder cancer.","method":"Co-immunoprecipitation of USP16 with IGF2BP3; ubiquitination assays; lncRNA-protein interaction assays; Hippo pathway reporter","journal":"Cancer letters","confidence":"Low","confidence_rationale":"Tier 3 — co-IP and ubiquitination in cancer context, single study, mechanistic detail limited","pmids":["35953000"],"is_preprint":false}],"current_model":"USP16 (Ubp-M) is a deubiquitinase whose primary established function is removal of monoubiquitin from histone H2AK119 (and H2AK15) to antagonize PRC1-mediated transcriptional silencing; its ZnF-UBP/BUZ domain specifically senses free ubiquitin C-termini and relieves catalytic product inhibition; CDK1-mediated S552 phosphorylation and O-GlcNAcylation at T203/S214 regulate its nuclear localization and activity; it also deubiquitinates multiple non-histone substrates including Plk1, c-Myc, calcineurin A, IKKβ, JAK1, KEAP1, Drp1, NLRP3, E2F1, and RPS27a on late cytoplasmic pre-40S ribosomes, and cross-reacts with ISG15 and Fubi, positioning USP16 as a multi-substrate deubiquitinase that coordinates cell cycle progression, stem cell self-renewal, DNA damage response, immune signaling, ribosome biogenesis, and inflammatory pathways."},"narrative":{"teleology":[{"year":1999,"claim":"Identification of USP16 as a mitotically regulated H2A deubiquitinase established the first direct link between ubiquitin removal from histones and cell cycle control.","evidence":"In vitro deubiquitination of H2A by recombinant Ubp-M; phosphorylation by mitotic extracts; GFP-fusion imaging showing cytoplasmic localization and mitotic chromosome association of catalytic mutants with cell cycle arrest phenotype","pmids":["10077596"],"confidence":"High","gaps":["Phosphorylation site and responsible kinase not yet identified","In vivo chromatin substrates uncharacterized","Mechanism of cytoplasmic retention unknown"]},{"year":2007,"claim":"Structural determination of the ZnF-UBP/BUZ domain revealed how USP16 specifically senses free ubiquitin C-termini, explaining its selectivity for unconjugated ubiquitin and providing a framework for understanding substrate engagement.","evidence":"NMR solution structure; ubiquitin-binding mapping; fluorescence polarization showing abolition of binding upon G76 carboxylate modification","pmids":["17512543"],"confidence":"High","gaps":["How BUZ domain integrates with catalytic domain during substrate processing unknown","No full-length structure available","Histone H3-H4 tetramer binding significance not clarified until 2010"]},{"year":2013,"claim":"Two parallel advances established USP16's physiological significance: triplication in a Down syndrome mouse model causally reduced stem cell self-renewal via H2AK119ub-Cdkn2a derepression, while CDK1 phosphorylation at S552 was shown to control nuclear entry by disrupting CRM1 interaction.","evidence":"Ts65Dn trisomic mice with rescue by Usp16 allele reduction; CDK1/cyclin B in vitro kinase assay with MS-identified S552; CRM1 co-IP; flow cytometry cell cycle analysis","pmids":["24025767","24013421"],"confidence":"High","gaps":["Whether S552 phosphorylation affects substrate specificity in vivo unknown","Downstream chromatin targets beyond Cdkn2a not mapped genome-wide","Precise timing of nuclear entry relative to chromatin deubiquitination unclear"]},{"year":2014,"claim":"Discovery that HERC2 recruits USP16 and that USP16 deubiquitinates both H2AK119 and H2AK15 broadened its chromatin substrate range and connected it to DNA damage response signaling.","evidence":"Reciprocal co-IP with domain mapping; in vitro deubiquitination of H2AK119ub and H2AK15ub; siRNA with ubiquitin foci quantification after DNA damage","pmids":["25305019"],"confidence":"High","gaps":["How USP16 is released from HERC2 during damage response unclear","Relative contribution to H2AK15 versus H2AK119 in vivo unresolved","Whether HERC2 modulates USP16 catalytic activity directly unknown"]},{"year":2015,"claim":"Conditional knockout and identification of a non-histone substrate established USP16 as both essential for hematopoiesis (via PRC1-counterbalancing H2AK119ub regulation of Cdkn1a) and a regulator of mitotic fidelity (via Plk1 deubiquitination at kinetochores).","evidence":"Bone marrow conditional KO with ChIP-seq, RNA-seq, and Cdkn1a rescue; Plk1 co-IP and ubiquitination assay with kinetochore localization imaging and chromosome alignment phenotype","pmids":["26699484","26323689"],"confidence":"High","gaps":["Full repertoire of PRC1-counterbalanced target genes not defined","How USP16 is recruited to kinetochores unknown","Whether Plk1 deubiquitination requires the BUZ domain untested"]},{"year":2019,"claim":"Identification of calcineurin A as a K29-linked polyubiquitin substrate revealed USP16's role in calcium-NFAT signaling and T cell function, extending its biology well beyond chromatin.","evidence":"K327 site and K29 linkage mapping; T cell-specific conditional KO with reduced EAE and IBD severity; NFAT reporter assays","pmids":["31135381"],"confidence":"High","gaps":["How calcium signal activates USP16 toward calcineurin A mechanistically unclear","Whether K29-linked deubiquitination is a general USP16 activity unknown","Calcineurin A deubiquitination not reconstituted with purified components"]},{"year":2020,"claim":"Three concurrent advances resolved USP16's spatial regulation, its role in ribosome biogenesis, and the protective logic of cytoplasmic sequestration: CRM1-dependent export keeps USP16 out of the nucleus to protect DSB repair; on late cytoplasmic pre-40S particles, USP16 deubiquitinates RPS27a for final 18S rRNA maturation.","evidence":"NES/NLS mutant analysis with leptomycin B and DSB repair assays; MS of RIOK1-trapped pre-ribosomal complexes; USP16 deletion with rRNA processing northern blots","pmids":["32005696","32129764"],"confidence":"High","gaps":["How USP16 is recruited to pre-40S particles unclear","Whether ribosome biogenesis function requires BUZ domain unknown","Relationship between cytoplasmic sequestration and ribosomal function not tested"]},{"year":2021,"claim":"Identification of IKKβ (K238) and JAK1 as USP16 substrates with in vivo validation positioned USP16 as a multi-pathway immune signaling regulator, while c-Myc stabilization connected it to oncogenic proliferation.","evidence":"IKKβ K238 site by MS with myeloid-conditional KO reducing IBD; JAK1 co-IP with Usp16 KO attenuating K-ras-driven lung tumorigenesis; c-Myc co-IP with xenograft rescue","pmids":["33523871","34294846","33546726"],"confidence":"High","gaps":["Selectivity determinants for IKKβ versus other IKK complex members unknown","In vitro reconstitution of JAK1 deubiquitination not shown","Whether c-Myc deubiquitination is direct or requires adaptor proteins unclear"]},{"year":2022,"claim":"USP16 was established as the major H2AK119ub deubiquitinase in oocytes required for zygotic genome activation, and its dosage-dependent regulation of Cdkn2a/BMP signaling was linked to Alzheimer's disease neuropathology.","evidence":"Oocyte-specific conditional KO with genome-wide ChIP-seq showing H2AK119ub at TSSs; AD mouse model with USP16 reduction rescuing cognitive deficits and astrogliosis","pmids":["35640597","35311644"],"confidence":"High","gaps":["Identity of specific zygotic genes requiring USP16-dependent deubiquitination for activation not fully resolved","Whether BMP pathway regulation involves direct deubiquitination of a BMP component unclear","Whether oocyte and somatic H2AK119ub functions share identical mechanisms unknown"]},{"year":2023,"claim":"Discovery of ISG15 and Fubi cross-reactivity, KEAP1 deubiquitination, and Drp1 stabilization dramatically expanded USP16's substrate repertoire to include ubiquitin-like proteins and mitochondrial/inflammasome regulators.","evidence":"ISG15 activity-based profiling with in vitro cleavage reconstitution; Fubi chemoproteomics with cleavage assays; KEAP1 reciprocal co-IP with hepatic IRI model; Drp1 co-IP/GST pulldown with gouty arthritis model","pmids":["38055744","37443395","37777507","37488647"],"confidence":"High","gaps":["Structural basis for ISG15/Fubi recognition by USP16 catalytic domain unknown","Whether KEAP1 deubiquitination is direct or scaffold-mediated not fully resolved","Relative physiological importance of Fubi versus ubiquitin processing undetermined"]},{"year":2024,"claim":"Cryo-EM structure of USP16 on an H2AK119Ub nucleosome revealed an acidic-patch-independent binding mode fundamentally distinct from PR-DUB, and O-GlcNAcylation was shown to tune catalytic activity and nuclear-cytoplasmic partitioning in opposition to CDK1 phosphorylation.","evidence":"Cryo-EM structure at resolution sufficient to resolve nucleosome contacts; site-specific O-GlcNAc mutants with in vitro deubiquitination assays and chromosome segregation imaging","pmids":["38918638","38462164"],"confidence":"High","gaps":["How O-GlcNAcylation structurally alters catalytic domain conformation unknown","Whether acidic-patch independence applies to all nucleosomal substrates untested","Contribution of conformational heterogeneity to substrate selectivity not quantified"]},{"year":2025,"claim":"Recent studies extended USP16 to mitochondrial localization alongside PRC1, S-nitrosylation-mediated activity regulation (C731) with KDM1A as a new substrate, and a kinetic mechanism whereby the ZnF-UBP domain relieves product inhibition in cis.","evidence":"Mitochondrial fractionation and PLA; SNO site identification at C731 with CME model; in vitro kinetic analysis of ZnF-UBP domain mutants and trans-activation experiments (preprint)","pmids":["41086206","41339351","bio_10.1101_2025.09.28.679104"],"confidence":"Medium","gaps":["Specific mitochondrial substrates of USP16 not identified","S-nitrosylation regulation awaits independent confirmation and structural characterization","Product inhibition relief mechanism demonstrated in preprint only, awaiting peer review"]},{"year":null,"claim":"Key unresolved questions include: the full structural basis for USP16's remarkable multi-substrate selectivity across ubiquitin, ISG15, and Fubi; how post-translational modifications (phosphorylation, O-GlcNAcylation, S-nitrosylation) are integrated to direct USP16 toward specific substrates in specific compartments; and whether USP16's mitochondrial localization reflects an autonomous deubiquitination program.","evidence":"","pmids":[],"confidence":"High","gaps":["No integrative structural model of full-length USP16 with post-translational modifications","Substrate selection logic across compartments not understood","Mitochondrial enzymatic activity not reconstituted"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,3,5,6,7,9,11,13,17,18,19,21,22,26]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,3,5,9,11,18,19]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[2,3,5,6,15,21]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,10,11]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,10,15]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[0,6,15,21]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[23]},{"term_id":"GO:0005840","term_label":"ribosome","supporting_discovery_ids":[11,19]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[0,4,7,22]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[3,5,6,15,21]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[5,10]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,13,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,9,13,14,17]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[11,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[26,28]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,15,16]}],"complexes":["late cytoplasmic pre-40S ribosomal subunit"],"partners":["HERC2","PLK1","PPP3CA","IKBKB","KEAP1","RPS27A","CRM1","MYC"],"other_free_text":[]},"mechanistic_narrative":"USP16 (Ubp-M) is a cysteine-class deubiquitinase that removes monoubiquitin from histone H2AK119 to antagonize PRC1-mediated transcriptional silencing, thereby regulating stem cell self-renewal, hematopoietic differentiation, oocyte-to-zygote transition, and cell cycle progression [PMID:10077596, PMID:24025767, PMID:26699484, PMID:35640597]. Its ZnF-UBP/BUZ domain senses free ubiquitin C-termini and relieves catalytic product inhibition, while CDK1-mediated S552 phosphorylation and O-GlcNAcylation at T203/S214 coordinately regulate nuclear–cytoplasmic shuttling and substrate selectivity; cryo-EM reveals a nucleosome-binding mode independent of the H2A-H2B acidic patch, mechanistically distinct from PR-DUB [PMID:17512543, PMID:24013421, PMID:38462164, PMID:38918638]. Beyond histones, USP16 deubiquitinates diverse non-histone substrates—Plk1 at kinetochores, calcineurin A (K29-linked chains) to enable NFAT signaling, IKKβ at K238 to promote NF-κB activation, JAK1, KEAP1, Drp1, NLRP3, and RPS27a on cytoplasmic pre-40S ribosomes—and additionally possesses ISG15 and Fubi cross-reactive protease activity required for ribosome maturation [PMID:26323689, PMID:31135381, PMID:33523871, PMID:32129764, PMID:38055744, PMID:37443395]. Triplication of USP16 in Down syndrome (trisomy 21) models causally reduces stem cell self-renewal and accelerates senescence through derepression of Cdkn2a, a phenotype rescued by reducing USP16 copy number [PMID:24025767]."},"prefetch_data":{"uniprot":{"accession":"Q9Y5T5","full_name":"Ubiquitin carboxyl-terminal hydrolase 16","aliases":["Deubiquitinating enzyme 16","Ubiquitin thioesterase 16","Ubiquitin-processing protease UBP-M","Ubiquitin-specific-processing protease 16"],"length_aa":823,"mass_kda":93.6,"function":"Specifically deubiquitinates 'Lys-120' of histone H2A (H2AK119Ub), a specific tag for epigenetic transcriptional repression, thereby acting as a coactivator (PubMed:17914355). Deubiquitination of histone H2A is a prerequisite for subsequent phosphorylation at 'Ser-11' of histone H3 (H3S10ph), and is required for chromosome segregation when cells enter into mitosis (PubMed:17914355). In resting B- and T-lymphocytes, phosphorylation by AURKB leads to enhance its activity, thereby maintaining transcription in resting lymphocytes. Regulates Hox gene expression via histone H2A deubiquitination (PubMed:17914355). Prefers nucleosomal substrates (PubMed:17914355). Does not deubiquitinate histone H2B (PubMed:17914355). Also deubiquitinates non-histone proteins, such as ribosomal protein RPS27A: deubiquitination of monoubiquitinated RPS27A promotes maturation of the 40S ribosomal subunit (PubMed:32129764). Also mediates deubiquitination of tektin proteins (TEKT1, TEKT2, TEK3, TEKT4 and TEKT5), promoting their stability","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9Y5T5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/USP16","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"BYSL","stoichiometry":0.2},{"gene":"RACK1","stoichiometry":0.2},{"gene":"RPS16","stoichiometry":0.2},{"gene":"TSR1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/USP16","total_profiled":1310},"omim":[{"mim_id":"613499","title":"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER A; HIST1H2AA","url":"https://www.omim.org/entry/613499"},{"mim_id":"604735","title":"UBIQUITIN-SPECIFIC PROTEASE 16; USP16","url":"https://www.omim.org/entry/604735"},{"mim_id":"190685","title":"DOWN SYNDROME","url":"https://www.omim.org/entry/190685"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/USP16"},"hgnc":{"alias_symbol":["Ubp-M"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y5T5","domains":[{"cath_id":"3.30.40.10","chopping":"34-57_69-144","consensus_level":"high","plddt":84.103,"start":34,"end":144},{"cath_id":"-","chopping":"198-356","consensus_level":"high","plddt":80.4335,"start":198,"end":356},{"cath_id":"3.90.70.10","chopping":"362-392_605-822","consensus_level":"medium","plddt":85.569,"start":362,"end":822}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y5T5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5T5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5T5-F1-predicted_aligned_error_v6.png","plddt_mean":66.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=USP16","jax_strain_url":"https://www.jax.org/strain/search?query=USP16"},"sequence":{"accession":"Q9Y5T5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y5T5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y5T5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y5T5"}},"corpus_meta":[{"pmid":"24025767","id":"PMC_24025767","title":"Usp16 contributes to somatic stem-cell defects in Down's syndrome.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/24025767","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10077596","id":"PMC_10077596","title":"A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10077596","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26699484","id":"PMC_26699484","title":"The histone H2A deubiquitinase Usp16 regulates hematopoiesis and hematopoietic stem cell function.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26699484","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25305019","id":"PMC_25305019","title":"The histone H2A deubiquitinase USP16 interacts with HERC2 and fine-tunes cellular response to DNA damage.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25305019","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33546726","id":"PMC_33546726","title":"USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/33546726","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37777507","id":"PMC_37777507","title":"FGF18 alleviates hepatic ischemia-reperfusion injury via the USP16-mediated KEAP1/Nrf2 signaling pathway in male mice.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37777507","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17512543","id":"PMC_17512543","title":"Solution structure of the Ubp-M BUZ domain, a highly specific protein module that recognizes the C-terminal tail of free ubiquitin.","date":"2007","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17512543","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31135381","id":"PMC_31135381","title":"USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance.","date":"2019","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/31135381","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26323689","id":"PMC_26323689","title":"Usp16 regulates kinetochore localization of Plk1 to promote proper chromosome alignment in mitosis.","date":"2015","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26323689","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29179215","id":"PMC_29179215","title":"Long Non-Coding RNA Linc-USP16 Functions As a Tumour Suppressor in Hepatocellular Carcinoma by Regulating PTEN Expression.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29179215","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32129764","id":"PMC_32129764","title":"USP16 counteracts mono-ubiquitination of RPS27a and promotes maturation of the 40S ribosomal subunit.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32129764","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35953000","id":"PMC_35953000","title":"LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.","date":"2022","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/35953000","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27633997","id":"PMC_27633997","title":"USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27633997","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35640597","id":"PMC_35640597","title":"USP16-mediated histone H2A lysine-119 deubiquitination during oocyte maturation is a prerequisite for zygotic genome activation.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35640597","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33523871","id":"PMC_33523871","title":"Substrate-specific recognition of IKKs mediated by USP16 facilitates autoimmune inflammation.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/33523871","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21090589","id":"PMC_21090589","title":"HDAC6 and Ubp-M BUZ domains recognize specific C-terminal sequences of proteins.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21090589","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38055744","id":"PMC_38055744","title":"USP16 is an ISG15 cross-reactive deubiquitinase that targets pro-ISG15 and ISGylated proteins involved in metabolism.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38055744","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37443395","id":"PMC_37443395","title":"Molecular basis for ubiquitin/Fubi cross-reactivity in USP16 and USP36.","date":"2023","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/37443395","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38918638","id":"PMC_38918638","title":"Structural and mechanistic basis for nucleosomal H2AK119 deubiquitination by single-subunit deubiquitinase USP16.","date":"2024","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38918638","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37488647","id":"PMC_37488647","title":"Deubiquitinase USP16 induces gouty arthritis via Drp1-dependent mitochondrial fission and NLRP3 inflammasome activation.","date":"2023","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37488647","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32005696","id":"PMC_32005696","title":"A potent nuclear export mechanism imposes USP16 cytoplasmic localization during interphase.","date":"2020","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/32005696","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24013421","id":"PMC_24013421","title":"Ubp-M serine 552 phosphorylation by cyclin-dependent kinase 1 regulates cell cycle progression.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/24013421","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35311644","id":"PMC_35311644","title":"Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer's model.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35311644","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34294846","id":"PMC_34294846","title":"The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34294846","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38462164","id":"PMC_38462164","title":"O-GlcNAcylation stimulates the deubiquitination activity of USP16 and regulates cell cycle progression.","date":"2024","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38462164","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30504774","id":"PMC_30504774","title":"Usp16 modulates Wnt signaling in primary tissues through Cdkn2a regulation.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30504774","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24076652","id":"PMC_24076652","title":"Usp16: key controller of stem cells in Down syndrome.","date":"2013","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/24076652","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32999190","id":"PMC_32999190","title":"USP16 Regulates the Stability and Function of LDL receptor by Deubiquitination.","date":"2020","source":"International heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/32999190","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32646283","id":"PMC_32646283","title":"Copy number variation of the USP16 gene and its association with milk traits in Chinese Holstein cattle.","date":"2020","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32646283","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34136489","id":"PMC_34136489","title":"CRISPR-Cas9 Editing of Human Histone Deubiquitinase Gene USP16 in Human Monocytic Leukemia Cell Line THP-1.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34136489","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41086206","id":"PMC_41086206","title":"Polycomb Repressive Complex 1 and USP16 localize to the mitochondrion and influence its function.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/41086206","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41339351","id":"PMC_41339351","title":"USP16 S-nitrosylation aggravates coronary microembolization-induced myocardial injury via repressing KDM1A-mediated glutathione homeostasis.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41339351","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41591834","id":"PMC_41591834","title":"USP16 drives psoriasis progression by deubiquitinating and stabilizing NLRP3 in keratinocytes.","date":"2026","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/41591834","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41894390","id":"PMC_41894390","title":"RUNX2 and USP16 stabilize MFRN2 to maintain pulmonary epithelial barrier integrity in sepsis-induced acute lung injury.","date":"2026","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/41894390","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41873345","id":"PMC_41873345","title":"USP16 promotes M2 polarization of macrophages in colorectal cancer by activating the Notch pathway via inducing the deubiquitination of E2F1.","date":"2026","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/41873345","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41718545","id":"PMC_41718545","title":"Development of a Dual Chemical Probe for the USP16 and HDAC6 Zinc-Finger Ubiquitin-Binding Domain.","date":"2026","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41718545","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.28.679104","title":"ZnF-UBP domains regulate deubiquitinase activity by relieving ubiquitin product inhibition","date":"2025-09-29","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.28.679104","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.04.17.649347","title":"Mechanism of USP21 autoinhibition and histone H2AK119 deubiquitination","date":"2025-04-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.17.649347","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889549","id":"PMC_8889549","title":"Generation and analysis of 280,000 human expressed sequence tags.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889549","citation_count":376,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20622874","id":"PMC_20622874","title":"Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne.","date":"2010","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20622874","citation_count":274,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25527291","id":"PMC_25527291","title":"Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/25527291","citation_count":259,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23287719","id":"PMC_23287719","title":"A strategy for modulation of enzymes in the ubiquitin system.","date":"2013","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23287719","citation_count":250,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27173435","id":"PMC_27173435","title":"An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173435","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22195557","id":"PMC_22195557","title":"The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types.","date":"2011","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/22195557","citation_count":176,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24493797","id":"PMC_24493797","title":"USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24493797","citation_count":157,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21399617","id":"PMC_21399617","title":"Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21.","date":"2011","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/21399617","citation_count":154,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28943312","id":"PMC_28943312","title":"Ubiquitin Linkage-Specific Affimers Reveal Insights into K6-Linked Ubiquitin Signaling.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28943312","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33903120","id":"PMC_33903120","title":"USP48 Is Upregulated by Mettl14 to Attenuate Hepatocellular Carcinoma via Regulating SIRT6 Stabilization.","date":"2021","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33903120","citation_count":124,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15231747","id":"PMC_15231747","title":"A protein interaction framework for human mRNA degradation.","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15231747","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21179169","id":"PMC_21179169","title":"Transcriptional activation of polycomb-repressed genes by ZRF1.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21179169","citation_count":119,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22298430","id":"PMC_22298430","title":"Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions.","date":"2012","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22298430","citation_count":105,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19910467","id":"PMC_19910467","title":"Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19910467","citation_count":102,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10799498","id":"PMC_10799498","title":"Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10799498","citation_count":98,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34876703","id":"PMC_34876703","title":"The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling.","date":"2021","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34876703","citation_count":93,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28254948","id":"PMC_28254948","title":"p38 inhibition provides anti-DNA virus immunity by regulation of USP21 phosphorylation and STING activation.","date":"2017","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28254948","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31488580","id":"PMC_31488580","title":"USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31488580","citation_count":83,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30865895","id":"PMC_30865895","title":"FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal-like Breast Cancer.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30865895","citation_count":82,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23395819","id":"PMC_23395819","title":"Identification of the E3 deubiquitinase ubiquitin-specific peptidase 21 (USP21) as a positive regulator of the transcription factor GATA3.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23395819","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18890,"output_tokens":7284,"usd":0.082965},"stage2":{"model":"claude-opus-4-6","input_tokens":10989,"output_tokens":4265,"usd":0.242355},"total_usd":0.68795,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":31088,"output_tokens":8438,"usd":0.109917},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":12420,"output_tokens":4255,"usd":0.252713}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"USP16 (Ubp-M) deubiquitinates histone H2A in vitro; is phosphorylated at the onset of mitosis by cdc2/cyclin B complexes and dephosphorylated at the metaphase/anaphase transition; mutant forms lacking the active-site cysteine associate with mitotic chromosomes and block cell division, leading to apoptosis; wild-type localizes to the cytoplasm\",\n      \"method\": \"In vitro deubiquitination assay, in vitro phosphorylation with mitotic extracts and purified cdc2/cyclin B, GFP-fusion live imaging, active-site cysteine mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay, active-site mutagenesis, in vitro kinase assay, live imaging; foundational paper\",\n      \"pmids\": [\"10077596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The BUZ domain of USP16 (Ubp-M) adopts a three-zinc-finger structure and specifically binds the free C-terminal tail of ubiquitin (RLRGG-COOH); modification of the G76 carboxylate by peptide or isopeptide bond abolishes BUZ-domain interaction, suggesting a 'free ubiquitin sensor' function\",\n      \"method\": \"NMR solution structure, binding affinity measurements (fluorescence polarization), ubiquitin peptide competition assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with functional binding validation\",\n      \"pmids\": [\"17512543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The BUZ domain of USP16 (Ubp-M) requires a C-terminal Gly-Gly motif for binding and can pull down the histone H3-H4 tetramer complex; its sequence specificity differs from HDAC6 BUZ domain, suggesting distinct substrate targeting\",\n      \"method\": \"OBOC peptide library screen, alanine scanning, fluorescence polarization binding assays, in vitro pull-down\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal binding assays in a single study\",\n      \"pmids\": [\"21090589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"USP16 removes ubiquitin from histone H2A lysine 119 (H2AK119), and triplication of Usp16 in Down syndrome mouse model (Ts65Dn) reduces stem cell self-renewal and accelerates senescence via decreased ubiquitination of Cdkn2a; siRNA-mediated Usp16 knockdown rescues these defects\",\n      \"method\": \"Mouse genetic model (Ts65Dn trisomic mice), siRNA knockdown, stem cell self-renewal assays, senescence assays, ubiquitination assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, replicated across multiple tissue types, high citation foundational paper\",\n      \"pmids\": [\"24025767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CDK1/cyclin B phosphorylates USP16 (Ubp-M) at serine 552; this phosphorylation is required for G2/M cell cycle progression and reduces USP16 interaction with the nuclear export protein CRM1, facilitating USP16 nuclear localization, but does not alter USP16 deubiquitination activity or tetramer formation\",\n      \"method\": \"Mass spectrometry, in vitro kinase assay, in vivo phosphorylation assay, Co-IP (CRM1 interaction), cell cycle analysis, cell proliferation assay\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay confirmed by mass spectrometry, functional cell cycle readout, protein interaction defined\",\n      \"pmids\": [\"24013421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"USP16 interacts with HERC2 through its coiled-coil domain binding to the HERC2 C-terminal HECT domain; HERC2 knockdown affects ubH2A levels via USP16; USP16 levels increase after DNA damage in a HERC2-dependent manner; USP16 deubiquitinates both H2A Lys-119 and H2A Lys-15 in vitro; increased USP16 acts as a negative regulator of DNA damage-induced ubiquitin foci and downstream repair factor recruitment\",\n      \"method\": \"Co-immunoprecipitation, domain-mapping experiments, in vitro deubiquitination assay, siRNA knockdown, DNA damage response assays (foci formation, factor recruitment)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro assay, reciprocal Co-IP with domain mapping, multiple functional readouts\",\n      \"pmids\": [\"25305019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Conditional deletion of Usp16 in mouse bone marrow increases global H2AK119 ubiquitination and causes lethality with loss of mature and progenitor hematopoietic cells; Usp16 and PRC1 counterbalance each other to regulate ubH2A levels; Usp16 target Cdkn1a (p21) mediates cell cycle and differentiation defects, as knockdown of Cdkn1a rescues both the altered cell cycle profile and differentiation defect of Usp16-deleted HSCs\",\n      \"method\": \"Conditional knockout mouse, ChIP-seq, RNA-seq, genetic epistasis (PRC1 subunit knockdown, Cdkn1a knockdown), flow cytometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with multiple orthogonal methods including ChIP-seq and genetic epistasis\",\n      \"pmids\": [\"26699484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"USP16 deubiquitinates Plk1, enhancing Plk1's interaction with kinetochore-localized protein BubR1 and retaining Plk1 at kinetochores to promote proper chromosome alignment in early mitosis; Usp16 knockdown causes increased ubiquitination and decreased kinetochore localization of Plk1\",\n      \"method\": \"Co-immunoprecipitation, in vivo ubiquitination assay, kinetochore localization imaging, siRNA knockdown, chromosome alignment assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, in vivo ubiquitination assay, functional localization with defined phenotypic readout\",\n      \"pmids\": [\"26323689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Usp16 modulates the Wnt signaling pathway in mammary epithelia and fibroblasts, at least partly through activation of Cdkn2a; Usp16 affects Rspo-mediated phosphorylation of LRP6; in Down syndrome model, triplication of Usp16 dampens Wnt activation\",\n      \"method\": \"Genetic mouse models (Ts65Dn), siRNA knockdown, mammary reconstitution assay, phosphorylation assay of LRP6, Axin2 reporter\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis and functional assays, single lab with multiple readouts\",\n      \"pmids\": [\"30504774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"USP16 deubiquitinates calcineurin A (CNA) at K29-linked polyubiquitin on lysine 327 in response to intracellular calcium stimulation; K29-linked ubiquitination of CNA impairs NFAT recruitment and transcription of NFAT-targeted genes; T cell-specific USP16 knockout mice show impaired peripheral T cell maintenance and reduced autoimmune disease severity\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K29-linkage identified), T cell-specific conditional knockout mouse, calcium stimulation experiments, NFAT transcription assay, EAE and IBD mouse models\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, conditional KO mice with specific molecular mechanism and disease readout\",\n      \"pmids\": [\"31135381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP16 is predominantly cytoplasmic during interphase due to an active nuclear export signal (NES) that maintains cytoplasmic localization; a non-canonical nuclear localization signal (NLS) plays a minimal role; USP16 is only transiently retained in the nucleus after mitosis; enforced nuclear localization abolishes DNA double-strand break repair, possibly due to unrestrained DUB activity; USP16 does not accumulate in the nucleus after DNA damage\",\n      \"method\": \"Live cell fluorescence microscopy, NES/NLS mutagenesis, nuclear export inhibitor experiments, DNA damage assays (DSB repair)\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments with mutational dissection of NES/NLS, functional DNA repair consequence\",\n      \"pmids\": [\"32005696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP16 is a component of late cytoplasmic pre-40S ribosomal subunits; USP16 removes ubiquitin from an internal lysine of ribosomal protein RPS27a/eS31; USP16 deletion leads to late 40S maturation defects including incomplete 18S rRNA processing and retarded recycling of ribosome biogenesis factors; RPS27a ubiquitination depends on active translation\",\n      \"method\": \"Mass spectrometry of RIOK1-trapped pre-ribosomal subunits, USP16 deletion (CRISPR KO), in vitro deubiquitination assay, rRNA processing assay, ribosome fractionation\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — MS identification, in vitro deubiquitination, genetic KO with functional ribosome maturation readout\",\n      \"pmids\": [\"32129764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP16 deubiquitinates c-Myc and stabilizes it; USP16 depletion suppresses prostate cancer cell growth in vitro and in vivo; overexpression of c-Myc rescues the effects of USP16 disruption\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, shRNA knockdown, mouse xenograft, c-Myc rescue experiment\",\n      \"journal\": \"Journal of experimental & clinical cancer research : CR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP, ubiquitination assay, in vivo rescue; single lab\",\n      \"pmids\": [\"33546726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP16 deubiquitinates IKKβ at lysine 238, selectively affecting p105 phosphorylation but not p65 or IκBα phosphorylation, thereby modulating NF-κB pathway substrate specificity; myeloid-conditional USP16 knockout mice exhibit reduced inflammatory bowel disease severity\",\n      \"method\": \"Mass spectrometry (IKKβ ubiquitination site), Co-IP, ubiquitination assay, conditional KO mouse, IBD mouse model\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — MS-identified substrate site, conditional KO with specific downstream phosphorylation readouts, disease model validation\",\n      \"pmids\": [\"33523871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP16 interacts with and deubiquitinates JAK1, promoting lung tumor growth by augmenting JAK1 signaling; USP16 deletion significantly attenuates K-rasG12D-induced lung tumorigenesis in mice; USP16 also modulates p38 activation downstream of RAS\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, conditional Usp16 deletion in K-ras lung tumor mouse model, in vivo tumorigenesis assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP, ubiquitination assay, in vivo mouse model; single lab\",\n      \"pmids\": [\"34294846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP16 is the major deubiquitinase for H2AK119ub1 in mouse oocytes; conditional knockout of Usp16 in oocytes does not impair meiotic maturation but causes defects in zygotic genome activation and developmental competence after fertilization, associated with persistent maternal H2AK119ub1 on zygotic genomes\",\n      \"method\": \"Conditional knockout mouse (oocyte-specific), ChIP-seq (genome-wide H2AK119ub1 dynamics), RNA-seq, fertilization and developmental assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — oocyte-specific KO with ChIP-seq and genome-wide functional validation\",\n      \"pmids\": [\"35640597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Genetic reduction of USP16 in an Alzheimer's disease mouse model rescues neural precursor cell self-renewal, prevents cognitive defects, and decreases astrogliosis; reduction of USP16 decreased Cdkn2a expression and mitigated aberrant BMP signaling pathway regulation\",\n      \"method\": \"Genetic reduction (heterozygous Usp16 allele), AD mouse model, NPC self-renewal assay, cognitive behavioral tests, astrogliosis measurement, BMP pathway analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic model with multiple functional readouts; mechanism partially defined\",\n      \"pmids\": [\"35311644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP16 interacts with and deubiquitinates KEAP1; FGF18 treatment reduces USP16 levels, leading to increased KEAP1 ubiquitination and Nrf2 activation; Nrf2 directly binds the USP16 promoter, forming a negative feedback loop with USP16\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, ChIP assay (Nrf2 binding to USP16 promoter), hepatic IRI mouse model, hepatic stellate cell-specific FGF18 knockout\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, ubiquitination assay, ChIP, in vivo genetic model with mechanistic feedback loop\",\n      \"pmids\": [\"37777507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP16 is an ISG15 cross-reactive protease: recombinant USP16 cleaves pro-ISG15 and ISG15 isopeptide-linked model substrates in vitro, and deISGylates substrates from cell lysates; USP16 depletion increases interferon-induced ISGylation; USP16-dependent ISG15 targets include metabolic enzymes (malate dehydrogenase, SOD1, aldolase A, GOT1)\",\n      \"method\": \"ISG15 activity-based profiling (chemoproteomics), in vitro cleavage assay (recombinant USP16), siRNA depletion with ISGylation measurement, interactome mass spectrometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro enzymatic assay, activity-based profiling, cell-based depletion; multiple orthogonal methods\",\n      \"pmids\": [\"38055744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP16 has dual ubiquitin/Fubi cleavage activity; crystal structures of the related USP36 complexed with Fubi and ubiquitin reveal substrate recognition mechanism; USP16 plays a synergistic role in Fubi-S30 maturation alongside USP36; chemoproteomics identified USP16 as a Fubi-active DUB\",\n      \"method\": \"Chemoproteomics (activity-based profiling), crystal structures (USP36-Fubi, USP36-Ub), in vitro Fubi C-terminal hydrolase assay, cellular Fubi-S30 maturation assay\",\n      \"journal\": \"Nature chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with in vitro functional validation and chemoproteomics\",\n      \"pmids\": [\"37443395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP16 mediates deubiquitination and stabilization of Drp1 through direct interaction; USP16 promotes gouty arthritis via Drp1-dependent mitochondrial fission and NLRP3 inflammasome/NF-κB activation in macrophages\",\n      \"method\": \"Co-IP, GST pull-down, ubiquitination assay, transmission electron microscopy, mitochondrial fission imaging, MSU-induced arthritis mouse model\",\n      \"journal\": \"Arthritis research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct interaction by GST pull-down and Co-IP, ubiquitination assay, in vivo model\",\n      \"pmids\": [\"37488647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structure of USP16 bound to H2AK119Ub nucleosome reveals a fundamentally distinct mode of H2AK119Ub deubiquitination compared to PR-DUB, with nucleosome recognition independent of the H2A-H2B acidic patch and conformational heterogeneity in the ubiquitin motif and H2A C-terminal tail\",\n      \"method\": \"Cryo-EM structure determination, structure-function analysis\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure with functional mechanistic interpretation\",\n      \"pmids\": [\"38918638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP16 is O-GlcNAcylated on Thr203 and Ser214; O-GlcNAcylation at Thr203 (adjacent to catalytic Cys204) reduces H2AK119 deubiquitination activity in vitro and in cells, while Ser214 O-GlcNAcylation has opposite effects; O-GlcNAcylation antagonizes CDK1-mediated Ser552 phosphorylation and promotes USP16 nuclear export; O-GlcNAcylation is required for Plk1 deubiquitination and subsequent chromosome segregation and cytokinesis\",\n      \"method\": \"Site-specific mutagenesis, in vitro deubiquitination assay, O-GlcNAcylation assay, phosphorylation-specific antibody, chromosome segregation imaging, cytokinesis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis of modification sites, in vitro enzyme assay, multiple functional cell cycle readouts\",\n      \"pmids\": [\"38462164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Both PRC1 and USP16 localize to mitochondria and directly influence mitochondrial function; mitochondria-specific depletion of PRC1 subunit RING2 alters ubiquitination of mitochondrial proteins including H2Aub; loss of PRC1 causes mitochondrial proteome alterations, loss of integrity, and impaired respiratory function\",\n      \"method\": \"Immunofluorescence, proximity ligation assay, cell fractionation, affinity-purified mitochondria biochemistry, auxin-induced RING2 depletion, proteomics, respiratory function assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization and biochemical methods; USP16 mitochondrial role is newly described in a single study\",\n      \"pmids\": [\"41086206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The ZnF-UBP domain of USP16 binds ubiquitin via its C-terminal GlyGly motif and also functions as an intramolecular product-release mechanism: slow ubiquitin release from the catalytic domain causes product inhibition, which is overcome by ZnF-UBP-mediated product release in cis; supplying a high-affinity ZnF-UBP domain in trans activates USP16\",\n      \"method\": \"In vitro enzyme kinetics assay, domain deletion/mutagenesis, trans-activation experiments, biochemical binding assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinetics with domain mutagenesis; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.09.28.679104\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP16 deubiquitinates KDM1A (K355); iNOS-mediated S-nitrosylation of USP16 at Cys731 inhibits USP16 activity, leading to increased KDM1A ubiquitination and degradation, which suppresses GSH biosynthesis genes and causes oxidative stress during coronary microembolization-induced myocardial injury\",\n      \"method\": \"Co-IP, ubiquitination assay, site-specific mutagenesis (C731), S-nitrosylation assay, chromatin analysis, mouse CME model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and ubiquitination assay with site mutagenesis, in vivo model; single lab\",\n      \"pmids\": [\"41339351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"USP16 directly binds and deubiquitinates NLRP3, removing K48-linked ubiquitination to stabilize NLRP3 protein, activate inflammasome activity, and promote keratinocyte proliferation and psoriasis progression\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48-linkage specific), siRNA knockdown, RNA-seq, NLRP3 rescue experiment, mouse psoriasis model\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP, ubiquitination assay, genetic rescue; single lab\",\n      \"pmids\": [\"41591834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"USP16 deubiquitinates and stabilizes mitoferrin-2 (MFRN2) by removing K27-linked ubiquitin chains at lysine 97; LPS-induced RUNX2 transcriptionally activates USP16 expression, which then reduces K27-ubiquitination of MFRN2, causing mitochondrial iron dyshomeostasis and promoting epithelial ferroptosis in acute lung injury\",\n      \"method\": \"ChIP assay (RUNX2 binding to USP16 promoter), Co-IP, ubiquitination assay (K27-linkage specific), site-specific mutagenesis (K97), ALI mouse model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP, Co-IP, and ubiquitination assay with site-specific mutagenesis; single lab\",\n      \"pmids\": [\"41894390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"USP16 directly interacts with and deubiquitinates the transcription factor E2F1, stabilizing it; stabilized E2F1 transcriptionally activates Notch1, driving M2 macrophage polarization in colorectal cancer via a USP16/E2F1/Notch1 axis\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, siRNA knockdown, genetic rescue (E2F1, Notch1 silencing), macrophage polarization assay\",\n      \"journal\": \"Cytotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP, ubiquitination assay, epistasis rescue; single lab\",\n      \"pmids\": [\"41873345\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"USP16 is a cytoplasmic-predominant deubiquitinase (actively excluded from the nucleus via a nuclear export signal) that canonically cleaves ubiquitin from histone H2AK119 and K15 (antagonizing PRC1 to regulate stem cell self-renewal, hematopoiesis, and zygotic genome activation), is regulated by CDK1-mediated phosphorylation at Ser552 (promoting nuclear entry at G2/M) and O-GlcNAcylation at Thr203/Ser214 (modulating catalytic activity and nuclear export), and additionally deubiquitinates multiple non-histone substrates—including Plk1 (kinetochore retention), calcineurin A (NFAT activation), IKKβ (selective NF-κB substrate specificity), c-Myc, JAK1, Drp1, KEAP1, NLRP3, KDM1A, MFRN2, and E2F1—while also acting as a deISGylase for ISG15-modified metabolic proteins and a Fubi protease contributing to 40S ribosomal subunit maturation via deubiquitination of RPS27a; its ZnF-UBP domain further regulates catalytic throughput by relieving product inhibition in cis.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"USP16 (Ubp-M) is phosphorylated at the onset of mitosis and dephosphorylated during the metaphase/anaphase transition; purified recombinant Ubp-M deubiquitinates histone H2A in vitro; the wild-type protein localizes to the cytoplasm, while catalytically inactive mutants (lacking the active-site cysteine) associate with mitotic chromosomes and cause cell cycle arrest and apoptosis upon transfection.\",\n      \"method\": \"In vitro deubiquitination assay with recombinant protein; in vitro phosphorylation with mitotic extracts and purified cdc2/cyclin B; GFP-fusion live-cell imaging; transfection of mutant constructs with viability readout\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro enzymatic assay, mutagenesis, direct localization imaging, and functional cell-cycle phenotype in a single foundational study\",\n      \"pmids\": [\"10077596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The BUZ domain of Ubp-M (USP16) adopts a structure with three zinc-binding sites forming a pair of cross-braced ring fingers within a third zinc finger; this domain specifically recognizes the free C-terminal tail of ubiquitin (GlyGly-COOH), and any modification of the G76 carboxylate abolishes binding, defining a 'free ubiquitin sensor' function.\",\n      \"method\": \"NMR solution structure determination; ubiquitin-binding mapping by NMR; fluorescence polarization binding assays with C-terminal ubiquitin peptides\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with functional binding validation by multiple assays\",\n      \"pmids\": [\"17512543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The BUZ domain of Ubp-M (USP16) exhibits sequence-specific recognition of C-terminal GlyGly-containing peptides; it binds the histone H3–H4 tetramer complex in vitro pull-down, and its sequence specificity differs from that of the HDAC6 BUZ domain.\",\n      \"method\": \"One-bead-one-compound peptide library screening; alanine scanning; fluorescence polarization binding assays; in vitro pull-down with histone complexes\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted binding with multiple orthogonal methods and mutagenesis\",\n      \"pmids\": [\"21090589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Triplication of Usp16 in Ts65Dn (Down syndrome model) mice reduces self-renewal of hematopoietic stem cells, mammary epithelial cells, neural progenitors, and fibroblasts; Usp16 removes ubiquitin from histone H2A lysine 119 (H2AK119); elevated Usp16 is associated with decreased ubiquitination of Cdkn2a and accelerated senescence; reduction of Usp16 by one allele or siRNA rescues these defects.\",\n      \"method\": \"Mouse genetic model (Ts65Dn trisomic); siRNA knockdown; colony and self-renewal assays; histone H2A deubiquitination assays; senescence assays; human tissue overexpression/knockdown experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genetic and biochemical methods, replicated in mouse and human systems, highly cited foundational study\",\n      \"pmids\": [\"24025767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CDK1 (cyclin-dependent kinase 1)/cyclin B phosphorylates USP16 (Ubp-M) at serine 552; this phosphorylation is required for G2/M cell cycle progression and reduces interaction with the nuclear export protein CRM1, thereby facilitating USP16 nuclear localization during mitosis; S552 phosphorylation does not affect deubiquitination activity or substrate specificity.\",\n      \"method\": \"Mass spectrometry identification of phosphorylation site; in vitro kinase assay with purified CDK1/cyclin B; in vivo phosphorylation assays; co-immunoprecipitation with CRM1; cell cycle analysis by flow cytometry\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay plus in vivo validation, MS identification, functional cell cycle phenotype\",\n      \"pmids\": [\"24013421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"USP16 interacts with HERC2 through its coiled-coil domain (HERC2 binds via its C-terminal HECT domain); HERC2 knockdown affects ubiquitinated H2A levels through USP16; USP16 levels increase in response to DNA damage in a HERC2-dependent manner; increased USP16 negatively regulates DNA damage-induced ubiquitin foci formation and downstream factor recruitment; USP16 deubiquitinates both H2AK119 and H2AK15 ubiquitination in vitro.\",\n      \"method\": \"Co-immunoprecipitation; domain-mapping experiments; in vitro deubiquitination assay; siRNA knockdown; immunofluorescence for ubiquitin foci; DNA damage response assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro enzymatic assay, reciprocal co-IP domain mapping, and multiple functional readouts\",\n      \"pmids\": [\"25305019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Conditional deletion of Usp16 in mouse bone marrow increases global H2AK119 ubiquitination and causes lethality with dramatic reduction of mature hematopoietic and progenitor cells; ChIP-seq showed Usp16 bound hematopoietic regulator genes; Usp16 and PRC1 counterbalance each other for H2A ubiquitination; Usp16 deletion alters cell cycle via upregulation of Cdkn1a (p21), and Cdkn1a knockdown rescues the differentiation defect.\",\n      \"method\": \"Conditional knockout mouse; ChIP-seq; RNA-seq; flow cytometry; PRC1 subunit knockdown rescue experiment; cell cycle analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with multiple orthogonal genomic and functional assays, genetic epistasis with PRC1 and Cdkn1a\",\n      \"pmids\": [\"26699484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"USP16 deubiquitinates Plk1 (Polo-like kinase 1), enhancing its interaction with kinetochore protein BubR1 and retaining Plk1 at kinetochores during early mitosis; USP16 knockdown increases Plk1 ubiquitination and decreases kinetochore-localized Plk1, causing chromosome misalignment.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assays; siRNA knockdown; immunofluorescence for kinetochore localization; chromosome alignment assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, ubiquitination assay, direct localization imaging with functional chromosome alignment readout\",\n      \"pmids\": [\"26323689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Usp16 modulates the Wnt signaling pathway in mammary epithelia, fibroblasts and MEFs; reduced Usp16 increases tissue responsiveness to Wnt (upregulation of Axin2), expands the basal mammary compartment, and increases regeneration; this regulation is mediated at least partly through Cdkn2a activation and affects Rspo-mediated phosphorylation of LRP6; in Down syndrome model (Ts65Dn), extra Usp16 copy dampens Wnt activation, and genetic Wnt upregulation rescues proliferation defects.\",\n      \"method\": \"Mouse genetic models (Usp16 reduction, Ts65Dn); mammary epithelial regeneration assays; Wnt target gene expression; LRP6 phosphorylation western blot; in vitro and in vivo epithelial repopulation assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models and functional assays but pathway placement is indirect (LRP6 phosphorylation) without full reconstitution\",\n      \"pmids\": [\"30504774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Calcineurin A (CNA) is constitutively ubiquitinated on K327 with K29-linked polyubiquitin chains, impairing NFAT recruitment; USP16 removes this ubiquitin in response to intracellular calcium stimulation, enabling NFAT-targeted gene transcription; USP16 deficiency prevents calcium-triggered CNA deubiquitination, causing defective T cell maintenance and proliferation; T cell-specific USP16 knockout mice show reduced autoimmune encephalitis and IBD severity.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assays identifying K327 site and K29 linkage; T cell-specific knockout mice; NFAT transcription reporter assays; in vivo disease models (EAE, IBD)\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — site-specific ubiquitination mapping, conditional KO with multiple in vivo disease readouts, mechanistic link to NFAT signaling\",\n      \"pmids\": [\"31135381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP16 is predominantly cytoplasmic during all interphase cell cycle phases due to a nuclear export signal (NES) that drives CRM1-dependent export; a non-canonical nuclear localization signal (NLS) has minimal role in nuclear entry; USP16 is only transiently retained in the nucleus after mitosis; forced nuclear localization of USP16 abolishes DNA double-strand break (DSB) repair, indicating that cytoplasmic exclusion protects nuclear DSB repair from unrestrained USP16 DUB activity.\",\n      \"method\": \"Fluorescence live-cell imaging; NES/NLS mutant analysis; leptomycin B treatment (CRM1 inhibition); DNA damage assays with enforced nuclear USP16; cell fractionation\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments with mutational dissection, functional consequence for DSB repair established\",\n      \"pmids\": [\"32005696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP16 is a component of late cytoplasmic pre-40S ribosomal subunits; it deubiquitinates an internal lysine of ribosomal protein RPS27a/eS31; USP16 deletion causes defects in final 18S rRNA processing and retarded recycling of late-acting ribosome biogenesis factors, revealing a role in the ultimate step of 40S subunit maturation; RPS27a ubiquitination depends on active translation.\",\n      \"method\": \"Mass spectrometry of pre-ribosomal complexes trapped on RIOK1; USP16 deletion; northern blot for rRNA processing; factor recycling assays; ubiquitination analysis of RPS27a\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS identification in native complex, genetic deletion with specific rRNA processing phenotype, and biochemical substrate mapping\",\n      \"pmids\": [\"32129764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP16 deubiquitinates and stabilizes c-Myc protein; USP16 interacts with c-Myc by co-immunoprecipitation and co-localization; USP16 depletion suppresses proliferation of castration-resistant prostate cancer cells in vitro and in vivo; c-Myc overexpression rescues USP16 depletion phenotype.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assays; shRNA knockdown; xenograft mouse model; c-Myc rescue experiment\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — co-IP and ubiquitination assay with in vivo rescue, but in vitro deubiquitination reconstitution not described\",\n      \"pmids\": [\"33546726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP16 deubiquitinates IKKβ on K238, and this deubiquitination selectively promotes IKKβ-mediated phosphorylation of p105 (NF-κB1) without directly affecting p65 or IκBα phosphorylation; myeloid-conditional USP16 knockout mice exhibit reduced IBD severity.\",\n      \"method\": \"Mass spectrometry identification of IKKβ ubiquitination site; co-immunoprecipitation; ubiquitination assays; myeloid-specific conditional KO mouse; IBD disease model; substrate-specific phosphorylation analysis\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS site identification, mechanistic substrate specificity demonstrated, conditional KO in vivo validation\",\n      \"pmids\": [\"33523871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP16 interacts with and deubiquitinates JAK1, thereby promoting JAK1 signaling and lung tumor growth in K-RAS-driven tumorigenesis; Usp16 deletion in mice significantly attenuates K-rasG12D-induced lung tumorigenesis; USP16 upregulation upon RAS activation also prevents ROS-induced p38 activation.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assays; Usp16 conditional KO in K-rasG12D mouse lung tumor model; ROS and p38 signaling analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — co-IP and ubiquitination assay with in vivo genetic model, but in vitro JAK1 deubiquitination reconstitution not shown\",\n      \"pmids\": [\"34294846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP16 is the major deubiquitinase for H2AK119ub1 in mouse oocytes; conditional knockout of Usp16 in oocytes does not impair survival, growth, or meiotic maturation, but causes defects in zygotic genome activation and developmental competence after fertilization, associated with high levels of maternal H2AK119ub on zygotic genomes; ChIP-seq revealed H2AK119ub1 is enriched at TSSs of maternal genes in fully grown oocytes and declines during meiotic resumption in a USP16-dependent manner.\",\n      \"method\": \"Oocyte-specific conditional knockout; ChIP-seq for H2AK119ub1 genome-wide; embryo development assays; immunofluorescence\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with genome-wide ChIP-seq and specific developmental phenotype\",\n      \"pmids\": [\"35640597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Reduction of USP16 in a mouse Alzheimer's disease model prevents neural precursor cell (NPC) self-renewal defects, cognitive deficits, and astrogliosis in vivo; this operates through decreased Cdkn2a expression and mitigation of aberrant BMP signaling pathway activation, identifying BMP pathway regulation as a novel USP16 function.\",\n      \"method\": \"Mouse AD model; genetic reduction of USP16; NPC self-renewal assays; in vivo cognitive testing; astrogliosis quantification; gene expression analysis for Cdkn2a and BMP pathway\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with cognitive and cellular phenotypes, but BMP mechanistic link relies on expression analysis rather than direct biochemical demonstration\",\n      \"pmids\": [\"35311644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP16 interacts with and deubiquitinates KEAP1; FGF18 treatment reduces USP16 levels, leading to increased KEAP1 ubiquitination and Nrf2 activation; Nrf2 directly binds the USP16 promoter forming a negative feedback loop; this USP16/KEAP1/Nrf2 axis mediates FGF18 protection against hepatic ischemia-reperfusion injury.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assays; ChIP for Nrf2 binding to USP16 promoter; USP16 knockdown/overexpression; hepatic IRI mouse model; HSC-specific FGF18 deletion\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, ubiquitination assay, ChIP, and in vivo genetic models establishing the pathway\",\n      \"pmids\": [\"37777507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP16 is an ISG15 cross-reactive protease identified by ISG15 activity-based profiling; recombinant USP16 cleaves pro-ISG15 and ISG15 isopeptide-linked model substrates in vitro, and deISGylates substrates from cell lysates; USP16 depletion increases interferon-induced ISGylation; USP16-dependent ISG15 substrates include metabolic enzymes (malate dehydrogenase, SOD1, fructose-bisphosphate aldolase A, glutamic-oxaloacetic transaminase 1).\",\n      \"method\": \"ISG15 activity-based profiling; in vitro cleavage assays with recombinant USP16 and ISG15 substrates; USP16 depletion with ISGylation analysis; interactome profiling of ISG15 substrates\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic reconstitution with activity-based profiling and substrate identification\",\n      \"pmids\": [\"38055744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP16 has dual ubiquitin/Fubi cleavage activity; chemoproteomics using a chemical tool kit identified USP16 alongside USP36 as Fubi proteases; USP16 plays a synergistic role in Fubi-S30 maturation, which is required for translationally competent ribosomes.\",\n      \"method\": \"Chemoproteomics with Fubi activity-based probes; in vitro Fubi cleavage assays; Fubi C-terminal hydrolase measurements; functional maturation assays\",\n      \"journal\": \"Nature chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — chemoproteomics discovery plus in vitro enzymatic reconstitution\",\n      \"pmids\": [\"37443395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP16 deubiquitinates and stabilizes Drp1 through direct interaction; USP16 is upregulated in MSU-stimulated macrophages and promotes gouty arthritis via Drp1-dependent mitochondrial fission and NF-κB/NLRP3 inflammasome activation.\",\n      \"method\": \"Co-immunoprecipitation; GST pull-down; ubiquitination assays; transmission electron microscopy of mitochondria; NLRP3 inflammasome activation assays; gouty arthritis mouse model\",\n      \"journal\": \"Arthritis research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct interaction by co-IP and GST pulldown with ubiquitination assays, but reconstituted deubiquitination of Drp1 not explicitly shown\",\n      \"pmids\": [\"37488647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structure of USP16 bound to H2AK119Ub nucleosome reveals a mode of H2AK119Ub deubiquitination fundamentally distinct from that of PR-DUB: USP16 recognizes the nucleosome independently of the H2A-H2B acidic patch, and shows conformational heterogeneity in the ubiquitin motif and H2A C-terminal tail.\",\n      \"method\": \"Cryo-EM structure determination of USP16-H2AK119Ub nucleosome complex\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure with functional mechanistic insight and comparison to PR-DUB mechanism\",\n      \"pmids\": [\"38918638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP16 is O-GlcNAcylated on Thr203 and Ser214; mutation of Thr203 (adjacent to catalytic Cys204) reduces deubiquitination activity toward H2AK119ub in vitro and in cells, while Ser214 mutation has the opposite effect; O-GlcNAcylation antagonizes CDK1-mediated S552 phosphorylation and promotes USP16 nuclear export; O-GlcNAcylation is required for deubiquitination of Plk1 and subsequent proper chromosome segregation and cytokinesis.\",\n      \"method\": \"Site-specific O-GlcNAc mutant analysis; in vitro H2A deubiquitination assays; phosphorylation-specific antibody; nuclear export assays; Plk1 ubiquitination assays; chromosome segregation and cytokinesis imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro enzymatic assay with site-specific mutagenesis, multiple substrates tested, and functional cell division phenotype\",\n      \"pmids\": [\"38462164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PRC1 and USP16 are both localized in mitochondria (in addition to the nucleus); mitochondria-specific depletion of PRC1 subunit RING2 alters ubiquitination of mitochondrial proteins including H2Aub; disruption of PRC1 causes alterations in mitochondrial proteome, mitochondrial integrity, and impaired respiratory function.\",\n      \"method\": \"Immunofluorescence; proximity ligation assays; cell fractionation; biochemical analyses of isolated/affinity-purified mitochondria; auxin-inducible mitochondria-specific RING2 depletion; proteomics; mitochondrial respiration assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple localization methods plus functional mitochondrial phenotype, but USP16's specific mitochondrial enzymatic activity not fully reconstituted\",\n      \"pmids\": [\"41086206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP16 S-nitrosylation at C731 by iNOS impairs its deubiquitinase activity toward KDM1A; during coronary microembolization, reduced USP16 activity leads to K355 ubiquitination and degradation of KDM1A, which normally removes H3K9me1/2 from GCLM and GLS promoters to maintain glutathione homeostasis.\",\n      \"method\": \"Site-specific S-nitrosylation identification; ubiquitination assays for KDM1A K355; ChIP for KDM1A at GCLM/GLS promoters; USP16 knockdown/overexpression; CME mouse model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — site-specific PTM identified with functional downstream pathway, but direct in vitro reconstitution of SNO-USP16 effect on KDM1A deubiquitination not fully shown\",\n      \"pmids\": [\"41339351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The ZnF-UBP domain of USP16 can bind ubiquitin substrates but also serves as a crucial regulator of enzyme kinetics by relieving product inhibition: after Ub cleavage, slow release of Ub from the catalytic domain causes product inhibition, which the ZnF-UBP domain overcomes in cis by capturing the released ubiquitin product; supplying the ZnF-UBP domain in trans activates USP16 and other USP enzymes.\",\n      \"method\": \"In vitro kinetic analysis of USP16 and ZnF-UBP domain mutants; trans-activation experiments with isolated ZnF-UBP domain; comparison across 8 of 14 ZnF-UBP-containing USPs\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinetic reconstitution with domain mutants, mechanistic enzyme kinetics demonstrating product inhibition relief\",\n      \"pmids\": [\"bio_10.1101_2025.09.28.679104\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"USP16 deubiquitinates and stabilizes NLRP3 in keratinocytes by removing K48-linked ubiquitination, thereby enhancing inflammasome activity; keratinocyte-specific USP16 knockdown ameliorates psoriatic phenotypes including epidermal hyperplasia; NLRP3 activator or overexpression counteracts the therapeutic effects of USP16 reduction.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assays; RNA-seq; keratinocyte-specific knockdown; psoriasis mouse model; rescue experiments with NLRP3 activator\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — co-IP and ubiquitination assay with in vivo rescue, specific K48 ubiquitination site identified\",\n      \"pmids\": [\"41591834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"USP16 deubiquitinates and stabilizes E2F1 through direct interaction; stabilized E2F1 transcriptionally activates Notch1; this USP16/E2F1/Notch1 axis drives M2 macrophage polarization in colorectal cancer.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assays; E2F1 and Notch1 rescue/knockdown experiments; macrophage polarization assays; conditioned medium tumor proliferation/invasion assays\",\n      \"journal\": \"Cytotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — co-IP and ubiquitination with functional rescue, but in vitro E2F1 deubiquitination reconstitution not described\",\n      \"pmids\": [\"41873345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"LPS-induced RUNX2 transcriptionally activates USP16 expression; USP16 then deubiquitinates mitoferrin-2 (MFRN2) at K97, removing K27-linked ubiquitin chains and stabilizing MFRN2, which leads to mitochondrial iron dyshomeostasis and epithelial ferroptosis in sepsis-induced acute lung injury.\",\n      \"method\": \"ChIP for RUNX2 binding to USP16 promoter; ubiquitination assays for MFRN2 K97; USP16 overexpression/knockdown; ferroptosis assays; ALI mouse model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — ChIP, site-specific ubiquitination mapping, and in vivo model, but direct in vitro reconstitution of USP16 deubiquitinating MFRN2 not fully demonstrated\",\n      \"pmids\": [\"41894390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP16 deubiquitinates and stabilizes LDL receptor (LDLR), preventing ubiquitylation-dependent LDLR degradation and thereby promoting LDL uptake.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assays; LDL uptake assays; USP16 overexpression/knockdown\",\n      \"journal\": \"International heart journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — co-IP and ubiquitination assay without in vitro reconstitution, single study\",\n      \"pmids\": [\"32999190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MNX1-AS1 lncRNA recruits USP16 to suppress IGF2BP3 degradation (deubiquitination), stabilizing IGF2BP3 and sustaining Hippo pathway inactivation in gallbladder cancer.\",\n      \"method\": \"Co-immunoprecipitation of USP16 with IGF2BP3; ubiquitination assays; lncRNA-protein interaction assays; Hippo pathway reporter\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — co-IP and ubiquitination in cancer context, single study, mechanistic detail limited\",\n      \"pmids\": [\"35953000\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"USP16 (Ubp-M) is a deubiquitinase whose primary established function is removal of monoubiquitin from histone H2AK119 (and H2AK15) to antagonize PRC1-mediated transcriptional silencing; its ZnF-UBP/BUZ domain specifically senses free ubiquitin C-termini and relieves catalytic product inhibition; CDK1-mediated S552 phosphorylation and O-GlcNAcylation at T203/S214 regulate its nuclear localization and activity; it also deubiquitinates multiple non-histone substrates including Plk1, c-Myc, calcineurin A, IKKβ, JAK1, KEAP1, Drp1, NLRP3, E2F1, and RPS27a on late cytoplasmic pre-40S ribosomes, and cross-reacts with ISG15 and Fubi, positioning USP16 as a multi-substrate deubiquitinase that coordinates cell cycle progression, stem cell self-renewal, DNA damage response, immune signaling, ribosome biogenesis, and inflammatory pathways.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"USP16 is a cysteine protease deubiquitinase with broad substrate specificity that integrates chromatin regulation, cell cycle progression, ribosome biogenesis, innate immune signaling, and mitochondrial homeostasis. Its canonical activity is the removal of ubiquitin from histone H2A at K119 and K15, directly antagonizing PRC1-mediated gene silencing to regulate stem cell self-renewal, hematopoiesis, and zygotic genome activation; cryo-EM structures reveal a nucleosome-recognition mode independent of the H2A-H2B acidic patch [PMID:38918638, PMID:24025767, PMID:26699484, PMID:35640597]. USP16 is predominantly cytoplasmic during interphase via an active NES, and CDK1-mediated phosphorylation at Ser552 promotes transient nuclear entry at G2/M, while O-GlcNAcylation at Thr203/Ser214 differentially modulates catalytic activity and nuclear export [PMID:32005696, PMID:24013421, PMID:38462164]. Beyond histones, USP16 deubiquitinates diverse non-histone substrates—including Plk1 (kinetochore retention), calcineurin A (NFAT signaling), IKKβ (NF-κB substrate selectivity), KEAP1, NLRP3, Drp1, JAK1, c-Myc, KDM1A, MFRN2, and E2F1—and additionally functions as a deISGylase for ISG15-conjugated metabolic enzymes and as a Fubi protease contributing to 40S ribosomal subunit maturation through deubiquitination of RPS27a [PMID:26323689, PMID:31135381, PMID:33523871, PMID:38055744, PMID:37443395, PMID:32129764].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"The foundational discovery established USP16 as a histone H2A deubiquitinase that is phosphorylated by cdc2/cyclin B at mitotic entry, linking deubiquitination to cell division control for the first time.\",\n      \"evidence\": \"In vitro H2A deubiquitination assay, in vitro kinase assay with mitotic extracts and cdc2/cyclin B, active-site Cys mutagenesis, GFP live imaging in HeLa cells\",\n      \"pmids\": [\"10077596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation site not mapped\", \"In vivo substrate specificity not defined\", \"Nuclear versus cytoplasmic activity not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Structural characterization of the ZnF-UBP (BUZ) domain revealed it specifically recognizes free ubiquitin C-termini but not conjugated ubiquitin, establishing that USP16 possesses an intrinsic ubiquitin-sensing module distinct from its catalytic domain.\",\n      \"evidence\": \"NMR solution structure, fluorescence polarization binding assays with modified ubiquitin C-terminal peptides\",\n      \"pmids\": [\"17512543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of BUZ domain in catalysis unknown\", \"Whether BUZ domain influences substrate selection in vivo untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two studies resolved USP16's physiological role and cell cycle regulation: USP16 triplication in Down syndrome accelerates senescence and impairs stem cell self-renewal via H2AK119ub-dependent Cdkn2a derepression, and CDK1-mediated phosphorylation at Ser552 promotes nuclear entry by disrupting CRM1-dependent export.\",\n      \"evidence\": \"Ts65Dn trisomic mouse model with siRNA rescue; mass spectrometry-identified Ser552 phosphorylation, in vitro kinase assay, Co-IP for CRM1 interaction, cell cycle analysis\",\n      \"pmids\": [\"24025767\", \"24013421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream chromatin targets beyond Cdkn2a not mapped genome-wide\", \"Phosphatase responsible for Ser552 dephosphorylation unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"HERC2 was identified as a scaffold that stabilizes USP16 after DNA damage, and USP16 was shown to deubiquitinate both H2AK119 and H2AK15, establishing it as a negative regulator of DNA damage-induced ubiquitin signaling.\",\n      \"evidence\": \"Reciprocal Co-IP with domain mapping (HERC2 HECT–USP16 coiled-coil), in vitro deubiquitination of K119- and K15-ubiquitinated H2A, siRNA knockdown with DNA damage foci quantification\",\n      \"pmids\": [\"25305019\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HERC2 stabilization is triggered after damage is unclear\", \"Whether USP16 acts on K13/K15 at DNA damage sites versus globally is unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Conditional knockout of Usp16 in bone marrow proved it is essential for hematopoiesis by counterbalancing PRC1-mediated H2AK119ub, with Cdkn1a (p21) as a key target gene, while a parallel study revealed the first non-histone substrate Plk1, whose deubiquitination promotes kinetochore retention and chromosome alignment.\",\n      \"evidence\": \"Conditional KO mouse with ChIP-seq, RNA-seq, genetic epistasis (Cdkn1a knockdown rescue); Co-IP, in vivo ubiquitination assay, kinetochore imaging for Plk1\",\n      \"pmids\": [\"26699484\", \"26323689\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of PRC1-target genes regulated by USP16 in HSCs not defined\", \"Ubiquitin chain type on Plk1 not determined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"USP16 was shown to deubiquitinate calcineurin A at K29-linked polyubiquitin chains, activating NFAT signaling in T cells; T cell-specific knockout impaired peripheral T cell maintenance and reduced autoimmune disease severity, establishing USP16 as a regulator of adaptive immunity.\",\n      \"evidence\": \"T cell-specific conditional KO mouse, K29-linkage-specific ubiquitination assays, calcium stimulation, NFAT transcription reporter, EAE and IBD models\",\n      \"pmids\": [\"31135381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase catalyzing K29-linked ubiquitination of CNA unknown\", \"Whether this mechanism operates in other calcineurin-dependent cell types untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Three discoveries expanded USP16's functional scope: its cytoplasmic predominance was attributed to an active NES (not passive exclusion), enforced nuclear localization was shown to impair DSB repair, and USP16 was identified as a component of cytoplasmic pre-40S ribosomal subunits that deubiquitinates RPS27a to enable late 18S rRNA processing.\",\n      \"evidence\": \"NES/NLS mutagenesis with live imaging and leptomycin B treatment; CRISPR KO with ribosome fractionation, in vitro deubiquitination of RPS27a, rRNA processing assay\",\n      \"pmids\": [\"32005696\", \"32129764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How USP16 is recruited to pre-40S particles is not defined\", \"Whether ribosome maturation defect contributes to cell cycle phenotypes is unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Multiple non-histone substrates were identified—IKKβ (K238 deubiquitination selectively affects p105 but not p65 phosphorylation), c-Myc (stabilization promotes prostate cancer growth), and JAK1 (stabilization augments lung tumorigenesis)—broadening USP16 from a chromatin regulator to a pleiotropic signaling node.\",\n      \"evidence\": \"MS-identified IKKβ K238 site, myeloid-conditional KO with IBD model; Co-IP and ubiquitination assays for c-Myc with xenograft rescue; conditional Usp16 deletion in K-ras lung tumor model for JAK1\",\n      \"pmids\": [\"33523871\", \"33546726\", \"34294846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How USP16 selects among diverse substrates in a given cell type is unknown\", \"Chain-type specificity for IKKβ, c-Myc, and JAK1 not fully characterized\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Oocyte-specific knockout revealed USP16 as the major H2AK119ub1 deubiquitinase required for zygotic genome activation, while O-GlcNAcylation at Thr203/Ser214 was shown to differentially modulate catalytic activity and antagonize CDK1-dependent nuclear entry, adding a metabolic sensing layer to USP16 regulation.\",\n      \"evidence\": \"Oocyte-conditional KO with ChIP-seq and developmental assays; site-specific mutagenesis of O-GlcNAc sites, in vitro deubiquitination, chromosome segregation imaging\",\n      \"pmids\": [\"35640597\", \"38462164\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"O-GlcNAc transferase and O-GlcNAcase dynamics during cell cycle not mapped for USP16\", \"Whether O-GlcNAcylation affects non-histone substrate selectivity is unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"USP16's enzymatic repertoire was expanded beyond ubiquitin: it was identified as a deISGylase that removes ISG15 from metabolic enzymes during interferon responses, and as a Fubi protease contributing to ribosomal protein S30 maturation, while also shown to deubiquitinate KEAP1 (modulating Nrf2 signaling in a feedback loop) and Drp1 (promoting mitochondrial fission and NLRP3 inflammasome activation).\",\n      \"evidence\": \"ISG15 activity-based chemoproteomics, in vitro ISG15 cleavage; crystal structures of USP36-Fubi informing USP16 Fubi activity, cellular Fubi-S30 maturation; Co-IP and ChIP for KEAP1-Nrf2 feedback; GST pull-down and TEM for Drp1-mitochondrial fission\",\n      \"pmids\": [\"38055744\", \"37443395\", \"37777507\", \"37488647\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of USP16 versus USP18 to global deISGylation not quantified\", \"Whether Fubi and ubiquitin cleavage activities are differentially regulated is unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Cryo-EM structure of USP16 bound to H2AK119Ub-nucleosome revealed a recognition mode fundamentally distinct from PR-DUB (BAP1/ASXL1), independent of the H2A-H2B acidic patch, explaining how two DUBs converge on the same substrate through different mechanisms.\",\n      \"evidence\": \"Cryo-EM structure determination and structure-function analysis\",\n      \"pmids\": [\"38918638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of USP16 with a non-histone substrate exists\", \"How the ZnF-UBP domain is positioned relative to the nucleosome-bound catalytic domain is unresolved in the structure\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"New substrates (KDM1A, MFRN2, E2F1, NLRP3) and regulatory inputs (S-nitrosylation at Cys731, RUNX2-mediated transcriptional activation) were identified, and the ZnF-UBP domain was shown to function as an intramolecular product-release mechanism that overcomes product inhibition by capturing released ubiquitin in cis.\",\n      \"evidence\": \"Co-IP and mutagenesis for KDM1A (C731 S-nitrosylation); ChIP and K27-linkage ubiquitination assay for MFRN2; Co-IP and rescue for E2F1/Notch1 axis; K48-linkage assay for NLRP3; in vitro enzyme kinetics with domain deletion/trans-activation for ZnF-UBP (preprint)\",\n      \"pmids\": [\"41339351\", \"41894390\", \"41873345\", \"41591834\", \"bio_10.1101_2025.09.28.679104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ZnF-UBP product-release mechanism awaits peer review\", \"S-nitrosylation of Cys731 identified only in cardiac injury context\", \"Whether E2F1 and NLRP3 deubiquitination are direct in purified systems has not been shown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how USP16 achieves substrate selectivity among its many targets in different cell types, whether its ubiquitin, ISG15, and Fubi protease activities are independently regulated, and what structural basis underlies its non-histone substrate recognition.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of USP16 with any non-histone substrate\", \"Cell-type-specific substrate hierarchy not determined\", \"Interplay between O-GlcNAcylation, S-nitrosylation, and phosphorylation has not been examined combinatorially\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 3, 5, 7, 9, 11, 12, 13, 14, 17, 18, 19, 20, 21, 22, 25, 26, 27, 28]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3, 5, 7, 9, 11, 12, 13, 14, 17, 20, 22, 25, 26, 27, 28]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 3, 5, 6, 15, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 10, 11]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 21]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 3, 5, 6, 15, 21, 22]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 4, 7, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 13, 18, 26]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [11, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 9, 13, 14, 17]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [5, 10]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"HERC2\",\n      \"PLK1\",\n      \"PPP3CA\",\n      \"IKBKB\",\n      \"KEAP1\",\n      \"RPS27A\",\n      \"DRP1\",\n      \"KDM1A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"USP16 (Ubp-M) is a cysteine-class deubiquitinase that removes monoubiquitin from histone H2AK119 to antagonize PRC1-mediated transcriptional silencing, thereby regulating stem cell self-renewal, hematopoietic differentiation, oocyte-to-zygote transition, and cell cycle progression [PMID:10077596, PMID:24025767, PMID:26699484, PMID:35640597]. Its ZnF-UBP/BUZ domain senses free ubiquitin C-termini and relieves catalytic product inhibition, while CDK1-mediated S552 phosphorylation and O-GlcNAcylation at T203/S214 coordinately regulate nuclear–cytoplasmic shuttling and substrate selectivity; cryo-EM reveals a nucleosome-binding mode independent of the H2A-H2B acidic patch, mechanistically distinct from PR-DUB [PMID:17512543, PMID:24013421, PMID:38462164, PMID:38918638]. Beyond histones, USP16 deubiquitinates diverse non-histone substrates—Plk1 at kinetochores, calcineurin A (K29-linked chains) to enable NFAT signaling, IKKβ at K238 to promote NF-κB activation, JAK1, KEAP1, Drp1, NLRP3, and RPS27a on cytoplasmic pre-40S ribosomes—and additionally possesses ISG15 and Fubi cross-reactive protease activity required for ribosome maturation [PMID:26323689, PMID:31135381, PMID:33523871, PMID:32129764, PMID:38055744, PMID:37443395]. Triplication of USP16 in Down syndrome (trisomy 21) models causally reduces stem cell self-renewal and accelerates senescence through derepression of Cdkn2a, a phenotype rescued by reducing USP16 copy number [PMID:24025767].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of USP16 as a mitotically regulated H2A deubiquitinase established the first direct link between ubiquitin removal from histones and cell cycle control.\",\n      \"evidence\": \"In vitro deubiquitination of H2A by recombinant Ubp-M; phosphorylation by mitotic extracts; GFP-fusion imaging showing cytoplasmic localization and mitotic chromosome association of catalytic mutants with cell cycle arrest phenotype\",\n      \"pmids\": [\"10077596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation site and responsible kinase not yet identified\", \"In vivo chromatin substrates uncharacterized\", \"Mechanism of cytoplasmic retention unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Structural determination of the ZnF-UBP/BUZ domain revealed how USP16 specifically senses free ubiquitin C-termini, explaining its selectivity for unconjugated ubiquitin and providing a framework for understanding substrate engagement.\",\n      \"evidence\": \"NMR solution structure; ubiquitin-binding mapping; fluorescence polarization showing abolition of binding upon G76 carboxylate modification\",\n      \"pmids\": [\"17512543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BUZ domain integrates with catalytic domain during substrate processing unknown\", \"No full-length structure available\", \"Histone H3-H4 tetramer binding significance not clarified until 2010\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two parallel advances established USP16's physiological significance: triplication in a Down syndrome mouse model causally reduced stem cell self-renewal via H2AK119ub-Cdkn2a derepression, while CDK1 phosphorylation at S552 was shown to control nuclear entry by disrupting CRM1 interaction.\",\n      \"evidence\": \"Ts65Dn trisomic mice with rescue by Usp16 allele reduction; CDK1/cyclin B in vitro kinase assay with MS-identified S552; CRM1 co-IP; flow cytometry cell cycle analysis\",\n      \"pmids\": [\"24025767\", \"24013421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether S552 phosphorylation affects substrate specificity in vivo unknown\", \"Downstream chromatin targets beyond Cdkn2a not mapped genome-wide\", \"Precise timing of nuclear entry relative to chromatin deubiquitination unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that HERC2 recruits USP16 and that USP16 deubiquitinates both H2AK119 and H2AK15 broadened its chromatin substrate range and connected it to DNA damage response signaling.\",\n      \"evidence\": \"Reciprocal co-IP with domain mapping; in vitro deubiquitination of H2AK119ub and H2AK15ub; siRNA with ubiquitin foci quantification after DNA damage\",\n      \"pmids\": [\"25305019\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How USP16 is released from HERC2 during damage response unclear\", \"Relative contribution to H2AK15 versus H2AK119 in vivo unresolved\", \"Whether HERC2 modulates USP16 catalytic activity directly unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Conditional knockout and identification of a non-histone substrate established USP16 as both essential for hematopoiesis (via PRC1-counterbalancing H2AK119ub regulation of Cdkn1a) and a regulator of mitotic fidelity (via Plk1 deubiquitination at kinetochores).\",\n      \"evidence\": \"Bone marrow conditional KO with ChIP-seq, RNA-seq, and Cdkn1a rescue; Plk1 co-IP and ubiquitination assay with kinetochore localization imaging and chromosome alignment phenotype\",\n      \"pmids\": [\"26699484\", \"26323689\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of PRC1-counterbalanced target genes not defined\", \"How USP16 is recruited to kinetochores unknown\", \"Whether Plk1 deubiquitination requires the BUZ domain untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of calcineurin A as a K29-linked polyubiquitin substrate revealed USP16's role in calcium-NFAT signaling and T cell function, extending its biology well beyond chromatin.\",\n      \"evidence\": \"K327 site and K29 linkage mapping; T cell-specific conditional KO with reduced EAE and IBD severity; NFAT reporter assays\",\n      \"pmids\": [\"31135381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How calcium signal activates USP16 toward calcineurin A mechanistically unclear\", \"Whether K29-linked deubiquitination is a general USP16 activity unknown\", \"Calcineurin A deubiquitination not reconstituted with purified components\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Three concurrent advances resolved USP16's spatial regulation, its role in ribosome biogenesis, and the protective logic of cytoplasmic sequestration: CRM1-dependent export keeps USP16 out of the nucleus to protect DSB repair; on late cytoplasmic pre-40S particles, USP16 deubiquitinates RPS27a for final 18S rRNA maturation.\",\n      \"evidence\": \"NES/NLS mutant analysis with leptomycin B and DSB repair assays; MS of RIOK1-trapped pre-ribosomal complexes; USP16 deletion with rRNA processing northern blots\",\n      \"pmids\": [\"32005696\", \"32129764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How USP16 is recruited to pre-40S particles unclear\", \"Whether ribosome biogenesis function requires BUZ domain unknown\", \"Relationship between cytoplasmic sequestration and ribosomal function not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of IKKβ (K238) and JAK1 as USP16 substrates with in vivo validation positioned USP16 as a multi-pathway immune signaling regulator, while c-Myc stabilization connected it to oncogenic proliferation.\",\n      \"evidence\": \"IKKβ K238 site by MS with myeloid-conditional KO reducing IBD; JAK1 co-IP with Usp16 KO attenuating K-ras-driven lung tumorigenesis; c-Myc co-IP with xenograft rescue\",\n      \"pmids\": [\"33523871\", \"34294846\", \"33546726\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Selectivity determinants for IKKβ versus other IKK complex members unknown\", \"In vitro reconstitution of JAK1 deubiquitination not shown\", \"Whether c-Myc deubiquitination is direct or requires adaptor proteins unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"USP16 was established as the major H2AK119ub deubiquitinase in oocytes required for zygotic genome activation, and its dosage-dependent regulation of Cdkn2a/BMP signaling was linked to Alzheimer's disease neuropathology.\",\n      \"evidence\": \"Oocyte-specific conditional KO with genome-wide ChIP-seq showing H2AK119ub at TSSs; AD mouse model with USP16 reduction rescuing cognitive deficits and astrogliosis\",\n      \"pmids\": [\"35640597\", \"35311644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of specific zygotic genes requiring USP16-dependent deubiquitination for activation not fully resolved\", \"Whether BMP pathway regulation involves direct deubiquitination of a BMP component unclear\", \"Whether oocyte and somatic H2AK119ub functions share identical mechanisms unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery of ISG15 and Fubi cross-reactivity, KEAP1 deubiquitination, and Drp1 stabilization dramatically expanded USP16's substrate repertoire to include ubiquitin-like proteins and mitochondrial/inflammasome regulators.\",\n      \"evidence\": \"ISG15 activity-based profiling with in vitro cleavage reconstitution; Fubi chemoproteomics with cleavage assays; KEAP1 reciprocal co-IP with hepatic IRI model; Drp1 co-IP/GST pulldown with gouty arthritis model\",\n      \"pmids\": [\"38055744\", \"37443395\", \"37777507\", \"37488647\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for ISG15/Fubi recognition by USP16 catalytic domain unknown\", \"Whether KEAP1 deubiquitination is direct or scaffold-mediated not fully resolved\", \"Relative physiological importance of Fubi versus ubiquitin processing undetermined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Cryo-EM structure of USP16 on an H2AK119Ub nucleosome revealed an acidic-patch-independent binding mode fundamentally distinct from PR-DUB, and O-GlcNAcylation was shown to tune catalytic activity and nuclear-cytoplasmic partitioning in opposition to CDK1 phosphorylation.\",\n      \"evidence\": \"Cryo-EM structure at resolution sufficient to resolve nucleosome contacts; site-specific O-GlcNAc mutants with in vitro deubiquitination assays and chromosome segregation imaging\",\n      \"pmids\": [\"38918638\", \"38462164\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How O-GlcNAcylation structurally alters catalytic domain conformation unknown\", \"Whether acidic-patch independence applies to all nucleosomal substrates untested\", \"Contribution of conformational heterogeneity to substrate selectivity not quantified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Recent studies extended USP16 to mitochondrial localization alongside PRC1, S-nitrosylation-mediated activity regulation (C731) with KDM1A as a new substrate, and a kinetic mechanism whereby the ZnF-UBP domain relieves product inhibition in cis.\",\n      \"evidence\": \"Mitochondrial fractionation and PLA; SNO site identification at C731 with CME model; in vitro kinetic analysis of ZnF-UBP domain mutants and trans-activation experiments (preprint)\",\n      \"pmids\": [\"41086206\", \"41339351\", \"bio_10.1101_2025.09.28.679104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific mitochondrial substrates of USP16 not identified\", \"S-nitrosylation regulation awaits independent confirmation and structural characterization\", \"Product inhibition relief mechanism demonstrated in preprint only, awaiting peer review\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the full structural basis for USP16's remarkable multi-substrate selectivity across ubiquitin, ISG15, and Fubi; how post-translational modifications (phosphorylation, O-GlcNAcylation, S-nitrosylation) are integrated to direct USP16 toward specific substrates in specific compartments; and whether USP16's mitochondrial localization reflects an autonomous deubiquitination program.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No integrative structural model of full-length USP16 with post-translational modifications\", \"Substrate selection logic across compartments not understood\", \"Mitochondrial enzymatic activity not reconstituted\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3, 5, 6, 7, 9, 11, 13, 17, 18, 19, 21, 22, 26]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 3, 5, 9, 11, 18, 19]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [2, 3, 5, 6, 15, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 10, 11]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 10, 15]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 6, 15, 21]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [23]},\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [11, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 4, 7, 22]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [3, 5, 6, 15, 21]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [5, 10]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 13, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 9, 13, 14, 17]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [11, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [26, 28]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 15, 16]}\n    ],\n    \"complexes\": [\n      \"late cytoplasmic pre-40S ribosomal subunit\"\n    ],\n    \"partners\": [\n      \"HERC2\",\n      \"PLK1\",\n      \"PPP3CA\",\n      \"IKBKB\",\n      \"KEAP1\",\n      \"RPS27A\",\n      \"CRM1\",\n      \"MYC\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}